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Thesis Overview 
This thesis consists of two chapters, a systematic review and an empirical paper, 
supplemented with additional information and supporting documents that can be found in the 
appendices.   Both chapters are intended for publication and thus have been written in the 
style of the identified journal for submission, The European Journal of Cancer Care.  The 
author guidelines followed can be found in Appendix A. 
Recent advancements in genetic testing have led to more accurate estimations of some 
individuals’ risks of developing breast cancer.  A number of options are available for women 
at increased risk of this illness, defined as those who have a 30% lifetime risk of developing 
breast cancer due to their family history and/or to deleterious genetic mutations (National 
Institute of Health and Clinical Excellence, 2013).  These alternatives are close surveillance 
using screening procedures, risk-reducing medication also known as chemoprevention, and 
surgical options.  The latter includes risk-reducing mastectomy (RRM), the surgical removal 
of breast tissue with or without immediate or delayed reconstruction.  There has been a 
notable increase in requests for RRM in recent years (Evans et al., 2015), and the 
knowledgebase regarding patients’ decision-making continues to grow.   In the United 
Kingdom, efforts have been made to establish guidelines for professionals working with 
patients who are considering RRM (British Psychological Society’s Division of Clinical 
Psychology Faculty for Oncology and Palliative Care, 2017). 
Given that the choice of undergoing RRM can be complex and influenced by wide-
ranging personal and societal factors, Chapter One aims to synthesise both qualitative and 
quantitative literature that explored women’s views of risk-reducing breast surgery and of 
factors affecting their decision-making regarding this procedure, specifically when they are 
considering at least one other risk management alternative due to being at familial high risk 
of developing breast cancer. 
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The findings of the literature review echo research within the wider literature 
acknowledging the multiple factors influencing patients’ reasons for requesting RRM, such 
as risk perceptions or estimations (Fielden, Brown, Saini, Beesley, & Salmon, 2017) and 
psychological factors such as fear and worry about cancer (Beesley, Holcombe, Brown, & 
Salmon, 2013).  In light of the above, Chapter Two aimed to gain a further understanding of 
patient’s views about RRM and of how they reach their decision to opt for this procedure.  
Using a qualitative methodology, this study contributes to the existing research by furthering 
our understanding of these issues in the context of decision-making theory, highlighting that 
patients who are at high risk of breast cancer might reach RRM decisions heuristically. 
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Abstract 
Women at increased risk of breast cancer face important decisions regarding risk-
reducing options and early detection strategies.  The aim of this mixed-methods systematic 
review was to examine women’s views of risk-reducing mastectomy and how they make 
decisions regarding this procedure when they are considering at least one other risk 
management alternative due to being at familial high risk of developing breast cancer.  A 
total of 13 studies published in peer-reviewed journals were included, of which three were 
qualitative studies and ten were quantitative studies.  Results evidenced that BRCA mutation 
carrier status, perceived risk of breast cancer, and cancer-related worry or fear might predict 
women’s RRM decisions.  Impact on body image and perceived confidence in risk-reducing 
or early detection options were highlighted as views and attitudes that might influence risk 
management strategy selection.  However, these variables were explored by small numbers of 
studies, and research designs differed greatly, limiting conclusions.  The great variation 
among participant samples also limited comparability of results.  Gaps in the literature are 
identified with suggestions for further research directions.  Future studies should explicitly 
incorporate theoretical models to explore how psychosocial variables and cultural differences 
impact women’s views of risk-reducing mastectomy and their decisions. 
 
Keywords: breast cancer, BRCA, risk-reducing mastectomy, mixed-methods systematic 
review. 
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Introduction 
Accounting for 15% of new cancer diagnoses, breast cancer is the most common cancer 
in the United Kingdom (UK), with an estimated 1 in 8 women being diagnosed with breast 
cancer during their lifetime (Cancer Research UK, 2015).  There are a number of ways of 
defining risk of developing breast cancer.  In the UK, guidelines by the National Institute for 
Health and Care Excellence (NICE, 2013) refer to three levels of risk: general population 
risk, moderate risk and high risk.  The latter indicates that women have a 30% or greater 
chance of developing the illness in their lifetime. 
The identification of two breast cancer susceptibility genes, BReast CAncer (BRCA) 1 
and 2 (Miki et al., 1994; Wooster et al., 1995), has represented a significant advancement in 
the prognosis, care and treatment of this type of cancer.  An estimated 5 – 10% of all breast 
cancers are caused by mutations in the BRCA1 and BRCA2 genes (Easton, Bishop, Ford, & 
Crockford, 1993), and individuals with a mutation in these genes have an elevated lifetime 
risk for breast cancer (55 – 85%) and ovarian cancer (16 – 60%) (Easton, Ford, & Bishop, 
1995; Struewing et al., 1997). 
Thus, genetic testing for deleterious mutations in the abovementioned genes is currently 
recommended for women with a strong family history of breast and ovarian cancer (Hampel 
et al., 2004) and with those who have received a diagnosis of breast cancer (NICE, 2013).  In 
addition to genetic and familial susceptibility, increased risk of developing breast cancer is 
also linked to personal history of the disease, age, age at menarche and menopause, age at 
pregnancy, weight, alcohol intake, hormone replacement therapy use, use of oral 
contraceptives (McPherson, Steel, & Dixon, 2000) and ethnicity or ancestry, with genetic 
mutations occurring more frequently in Ashkenazi Jews, French Canadians, or Icelanders 
(National Comprehensive Cancer Network, 2008). 
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In the UK, those who are identified as at moderate or high risk of breast cancer are 
offered risk management measures in order to decrease morbidity (NICE, 2013).  These 
evidence-based recommendations vary depending on women’s ages and risk factors, and 
include surveillance or screening, chemoprevention, and risk-reducing surgery. 
 
Risk-Reducing Options and Early Detection 
Radiographic mammograms and/or Magnetic Resonance Imaging (MRI) screening is 
not preventive of cancer, but can enable early detection of breast cancer and consequently 
improve its treatment and prognosis (NICE, 2013).  However, this type of surveillance can 
produce false positive and false negative results, which can cause worry and might lead to 
unnecessary treatment or lack thereof.   
The female hormone oestrogen is associated with the development and growth of the 
majority of breast cancers (Jensen & Jordan, 2003).  The use of Selective Estrogen Receptor 
Modulators (SERMs) such as tamoxifen or raloxifene, and of the aromatase inhibitor 
anastrozole can inhibit the development of breast cancer among women at increased risk of 
oestrogen-receptor positive breast cancer (NICE, 2013).  A recent meta-analysis from nine 
randomised SERM trials reported a 38% reduction in overall breast cancer incidence and a 
51% reduction in oestrogen-receptor positive tumours (Cuzick et al., 2013).  The preventive 
effect of tamoxifen can be long-lasting (Cuzik et al., 2015), however its use has been linked 
to increased risk of endometrial cancer and venous thromboembolisms, whilst its side effects 
including menopausal symptoms (The Royal Marsden NHS Foundation Trust, 2016). 
Risk-reducing mastectomy (RRM), also known as prophylactic mastectomy (PM), and 
risk-reducing oophorectomy (RRO) may significantly reduce the risk of developing breast 
and ovarian cancer for women who are carriers of mutated BRCA1 and BRCA2 genes 
(Burke et al., 1997). RRM i
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delayed breast reconstruction.  RRM can be bilateral (BRRM) if performed on both breasts, 
or contralateral (CRRM) if performed upon the non-affected breast after a treatment 
mastectomy.  RRM can result in an 85 – 90% decrease of cancer risk (Rebbeck, Kauff, & 
Domchek, 2009), however there remains a small risk of developing breast cancer after 
prophylactic surgery because the surgical removal of all breast tissue cannot be guaranteed 
(Lopez & Porter, 1996; Willemsen et al., 1998).  RRM is an irreversible surgical procedure 
and it is not without potential risks, including those associated with anaesthesia and post-
operative complications such as residual pain or discomfort in the chest area (Gahm, 
Wickman, & Brandberg, 2010).  Furthermore, postoperative regret after undergoing RRM 
has been reported in the literature, for example associated with factors such as psychological 
distress and the unavailability of psychological and rehabilitative support (Payne et al., 2000), 
cosmesis and concerns about body image (Gopie et al., 2013), and sexual dysfunction 
(Altschuler et al., 2008; Frost et al., 2000).  Nevertheless, RRM might provide psychological 
benefit for women who are at high risk of breast cancer and who fear developing the disease 
(Bebbington & Fallowfield, 2003), since it has been linked with decreased worry and distress 
(den Heijer et al., 2012) and a reduction in cancer-related intrusive thoughts (Bresser et al., 
2007). 
RRO is the surgical removal ovaries, whilst risk-reducing salpingo-oophorectomy 
(RRSO) is the surgical removal of fallopian tubes and ovaries, to lower the risk of developing 
ovarian cancer and breast cancer.  These surgical procedures may reduce the risk for ovarian 
cancers by 85% to 90% and of breast cancer by 40% to 70% (Finch et al., 2014); however, 
there remains a residual risk of developing peritoneal cancer (Rebbeck et al., 2009).  RRO 
and RRSO cause infertility, are associated with immediate surgical menopause and 
menopausal symptoms (Domcheck & Rebbeck, 2007), and can lead to an increased risk of 
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osteopenia and osteoporosis, cognitive dysfunction and cardiovascular disease (Guidozzi, 
2016). 
 
Factors Influencing RRM Decisions 
The management of an increased risk of breast cancer may pose decisional dilemmas 
for affected women.  Decision-making processes regarding breast cancer screening and risk 
management behaviours are influenced by women’s risk perceptions.  Research shows that 
despite genetic counselling, women with a family history of breast cancer tend to 
overestimate their risk (Caruso et al., 2009; Sivell et al., 2008).  Additionally, holding 
relatively accurate beliefs about their risk level is not always predictive of women’s 
engagement in the recommended risk management options (Keogh, McClaren, Apicella, & 
Hopper, 2011).  Furthermore, women’s intentions and decisions to undergo prophylactic 
mastectomies and oophorectomies are affected by psychological factors, such as perceived 
risks and benefits, and cancer-related worry (Antill et al., 2006; Madalinksa et al., 2007; van 
Dijk et al., 2003), which have been found to be predictive of more favourable attitudes 
towards RRM (Stefanek, Enger, Benkendorf, Flamm Honig, & Lerman, 1999).   
Socio-cultural factors influence norms and attitudes about breast cancer risk perception 
and preventive options, including among physicians (Bouchard et al., 2004; den Heijer et al., 
2013).  Therefore, these factors may play a role in risk-reducing decision-making (Julian-
Reynier et al., 2001; See et al., 2005) and in clinical recommendations for women at 
increased risk of breast and ovarian cancer (Eisinger, Geller, Burke, & Holtzman, 1999).  
which differ between countries.  Public awareness and media attention might also influence 
women’s choice or preference for RRM, for example shaping their perceptions of recovery 
and of aesthetic results (Braude, Laidsaar-Powell, Gilchrist, Kirsten, & Juraskowa., 2017).   
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Models for Health Prevention Decision-making  
A number of models have been developed and investigated to explain factors 
influencing health-related decisions and engagement. Evidence strongly indicates that 
individuals’ risk perceptions, risk preferences and decision-making processes are greatly 
influenced by emotional interpretations of information and inferential rules called heuristics 
(Lerner & Keltner, 2001; Loewenstein, 2001; Reyna, 2004).  Heuristics are mental operations 
which can be used simultaneously when processing complex information as a means of 
facilitating information processing and judgement, and can lead to both valid or erroneous 
conclusions (Kahneman, Slovic, & Tversky, 1982).  Several heuristics and affect reactions 
have been identified as influencing how patients construct their breast cancer risk perceptions 
including the availability, simulation, representativeness, affect, and perceived control 
heuristics, and combinations of these (Facione, 2002; Katapodi et al., 2004; Montgomery et 
al., 2003; Rees, Fry, & Cull, 2001). 
Dual process theories, accounting for how decisions are influenced by implicit or 
automatic processes as well as by explicit or conscious processes, may be relevant to 
understand how the experiences and attitudes of women at increased risk of breast cancer 
shape their preference for and uptake of specific risk management options. 
Petty and Cacioppo’s Elaboration Likelihood Model (ELM) (Petty & Cacioppo, 1986) 
is a dual process theory that has been used to understand behaviours that will reduce cancer 
risk, such as compliance with breast cancer screening (Drossaert, Boer, & Seydel, 1996).  It 
proposes two routes of processing stimuli, a central route and a peripheral one, with 
individuals being more likely to process information via one or the other depending on their 
motivations and their ability for critical evaluation.  According to the ELM model, 
information perceived to be personally relevant, and therefore affecting a person’s 
motivation, is more likely to be processed via the central route.  Information processed this 
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way is retained longer and is more likely to lead to attitudinal change that will be enduring 
and predictive of behaviours (Petty & Cacioppo, 1986).  Oppositely, individuals are more 
likely to engage in peripheral information processing if they lack motivation or capability to 
think critically about a topic; this might be due to their attitudes, perceived personal 
relevance, cognitive resources, and might rely on heuristics and social influence.  When 
information is processed via the peripheral route, individuals are more likely to maintain their 
attitudes or engage in attitudinal and behavioural change which is less durable. 
The aim of this review was to present a systematic synthesis of the existing quantitative 
and qualitative research data examining women’s views of RRM when they are considering 
breast cancer risk management strategies due to being at familial high risk of developing 
breast cancer.  Familial high risk of breast cancer is defined as an identified BRCA1/2 
mutation or known increased familial risk due to a family history consistent with an inherited 
susceptibility to breast cancer.  In particular, this mixed-method systematic review examines 
the questions: 
 
#! What influences the RRM decisions of women who are at familial high risk of breast 
cancer when they are considering at least one other risk management alternative? 
#! What are the predictors of their RRM decisions? 
 
Method 
In this mixed-method systematic review data from qualitative and quantitative 
published research findings are analysed and synthesised to provide a better understanding of 
individuals’ experiences and views (Heyvaert, Hannes, Maes, & Onghena., 2013). 
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Search Strategy 
Search terms were initially identified consulting literature reviews and articles 
published in peer-reviewed journals.  Further search terms were incorporated after scoping 
searches were conducted using electronic databases. The electronic databases PsycINFO 
(1879-2017), Medline (1948-2017), Web of Science (1900-2017), and Scopus (1960-2017) 
were searched for relevant published literature using the following keywords in combination: 
(“Risk reducing mastectom*” OR RRM OR “prophylactic mastectom*” OR “preventative 
mastectom*”) AND (Perception* OR attitude* OR opinion* OR view* OR belief* OR 
perspective*) AND (Wom* OR patient* OR survivor*).  The search strategies were based on 
the keywords being in titles, abstracts and keywords. 
Searches were combined and duplicates were removed prior to study selection using 
Endnote X7.  In addition, hand searches were also conducted for references from previous 
systematic reviews, as well as publications by key authors in the field, and the reference lists 
of identified publications.  Search alerts were set up via the abovementioned electronic 
databases until May 2017, which generated weekly emails updating the search results with 
newly published studies. 
 
Inclusion and Exclusion Criteria 
Following the search strategy, identified publications were assessed for inclusion in this 
review.  Studies with participants identified as at high familial risk of breast cancer, and 
studies where participants were BRCA1 and/or BRCA2 mutation carriers, were included.  
Studies that investigated participants’ views of two or more breast cancer risk management 
options, one of which was RRM or PM, were included. 
Studies were limited to those that included adult women participant samples.  Studies 
that investigated the opinions of health care professionals or family members, were excluded, 
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as were studies with participants were not identified as at increased familial risk of breast 
cancer.  Studies that were published in English, Spanish or Portuguese languages were 
included.  No restrictions on the date of publication were applied.  For quality control, only 
studies published in peer-reviewed journals were included.  Literature reviews and 
conference presentations, as well as case reports and unpublished dissertations were 
excluded.   
 
Study Selection 
As an initial stage, ESN screened all identified titles and abstracts of the search results 
for potential inclusion.  Subsequently, the studies identified as potentially relevant were read 
by ESN in order to ascertain whether they met inclusion criteria.  When it was unclear 
whether or not the studies should be included, as second opinion was sought (SB) and a joint 
decision reached.   
Reference lists and exclusion criteria applied were recorded at each stage (see 
Appendix B).  The process of study selection is presented using the Preferred Reporting 
Items for Systematic reviews and Meta-Analysis ([PRISMA] Moher, Liberati, Tetzlaff, & 
Altman, 2009) flow diagram in Figure 1.  This review included 13 studies, of which ten were 
quantitative and three were qualitative. 
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Figure 1.  PRISMA flow diagram displaying the article selection process. 
 
Quality Assessment 
Quality was not an exclusion criterion, however the Quality Assessment Tool for 
Studies with Diverse Designs ([QATSDD] Sirriyeh, Lawton, Gardner, & Armitage, 2012) 
was employed to assess study quality.  The 16-item QATSDD (Appendix C) has shown good 
reliability and validity for use in the quality assessment of studies (Sirriyeh et al., 2012) and 
can facilitate in-depth understanding of studies under review, including their strengths and 
limitations (Fenton, Lauckner, & Gilbert, 2015).  The quality assessment procedure was 
performed by ESN and reviewed by SB.  Where disagreement occurred, it was resolved by 
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both authors reaching a consensus.  The strengths and weaknesses in study methodology 
were considered when synthesising the studies, and thus the final synthesis was weighted by 
study quality.  Appendix C presents the QATSDD scoring for each study.   
 
Results 
Summary of Included Studies 
An overall summary of the characteristics of the studies included in this review is 
presented in Table 2.  The 13 eligible studies took place in nine countries: USA (n=5), UK 
(n=1), Canada (n=1), Italy (n=1), Belgium (n=1), Israel (n=1), Hong Kong (n=1), 
Netherlands (n=1), and Australia (n=1).  Three studies used qualitative methods, whereas the 
most frequent methodological design was quantitative (n=10).   
The most common quantitative data collection method was self-administered 
questionnaires (n=10).  The sample sizes in the studies ranged from 371 to 12.  A total of ten 
studies reported participants were identified as at high risk of breast cancer due to being 
BRCA1/2 mutation carriers; in five of these studies the BRCA1/2 mutation carriers 
constituted a subsample of participants, as the studies also included participants who were not 
BRCA1/2 mutation carriers.  In three studies the participants were women identified as at 
high risk of breast cancer due to familial risk.   
 
Results of Quantitative Studies 
This review included ten studies using quantitative methodologies with varied aims, with data 
primarily collected by means of self-administered questionnaires using a wide range of 
measures, as recorded in Table 1.  These studies varied also in their sample sizes (from n=62 
to n=312), as well as demographic characteristics such as age range, ethnicity and BRCA  
RRM PERCEPTIONS AND DECISION-MAKING AMONG WOMEN AT HIGH RISK OF BC 
! 16 
Table 1.   
Summary of Quantitative Studies  
Author(s), 
year 
Country Sample 
Sample 
characteristics of 
interest 
Design Aim(s) 
Data collection 
method 
Measures and data 
collected 
Predictors  Summary of results of interest 
Borreani 
et al. 
(2014) 
Italy 
C-A n=52 
C-UN n=27 
C-A age range: 30-70. 
C-UN age range: 26-
57 
Ethnicity: not stated. 
 
BRCA1/2 mutation 
carriers, who were 
either cancer-affected 
(C-A) or cancer-
unaffected (C-UN). 
Prospective 
Describe the impact of risk-
reducing options on 
psychological condition of 
BRCA1/2 carriers.   
Describe the distribution of 
preventive strategies. 
Compare psychosocial 
variables of women selecting 
surveillance or risk-reducing 
surgery. 
Self-report 
measures. 
HADS, 
Breast Cancer Worry 
Scale, 
Cancer-risk perception 
tool, 
Satisfaction with risk 
reducing strategy 
questions, 
Digital Body Photo Test, 
MOS SF-12. 
Psychological distress, 
Concerns about becoming ill 
with BC, 
Cancer-risk perception, 
Body image, 
Sociodemographic 
information, 
Oncological family history 
In BRCA1/2 mutation carriers, 
prophylactic surgery reduced the 
perceived risk and worry about 
cancer. 
C-A and C-UN mutation carriers 
have to be considered as two 
separate populations. 
Claes et al. 
(2005) 
Belgium 
n=68 (34 BRCA 
carriers, 34 non-
carriers) 
 
Carriers age mean: 
38.4 
Carriers age range:   
19 – 61 
Subsample of 
BRCA1/2 mutation 
carriers. 
Prospective 
Describe breast and ovarian 
cancer surveillance practices 
and prophylactic surgery. 
Evaluate the effect of BRCA 
carrier status on cancer 
screening practices. 
Provide insight into factors 
influencing women’s 
decisions about risk 
management strategies. 
Semi-
structured 
interview, 
Self-report 
questionnaires. 
Sociodemographic data, 
disease data, health-related 
behaviour, uptake of risk-
reducing surgery. 
Sociodemographic variables, 
Disease-related variables, 
Health-related behaviour, 
Illness perceptions, 
Cancer-specific distress, 
Attitudes and motives 
towards preventive options 
9% of BRCA mutation carriers 
underwent RRM. 
BRCA carriers adhered to cancer 
surveillance recommendations 
(clinical breast examination and 
mammography). 
75% of BRCA mutation carriers 
eligible for RRO had this 
procedure. 
Haroun et 
al. (2011) 
Canada 
n = 246. 
Age range: 26 – 66. 
Ethnicity: not stated. 
 
BRCA1/2 mutation 
carriers without breast 
cancer. 
Retrospec-
tive,  
Cross-
sectional 
Identify factors associated 
with a switch from MRI-
based surveillance to RRM. 
Measure satisfaction with the 
decision. 
Self-
administered 
questionnaire 
developed by 
researchers. 
 
Demographic data, family 
history of BC, satisfaction 
with screening, 
estimations of personal 
risk of BC, reasons to 
undergo RRM and 
satisfaction with it. 
BRCA 1 or BRCA 2, 
First-degree relative having 
BC, 
Perceived personal BC risk, 
Previous BSO, 
Benign breast biopsy, 
Satisfaction with MRI 
screening 
The women who elected RRM 
instead of MRI surveillance cited 
fear of cancer, previous cancer 
and concern about children as 
main reasons.  Women who 
perceived BC risk to be greater 
than 50% were more likely to opt 
for RRM.   
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Kram, 
Peretz & 
Sagi 
(2006) 
Israel 
n = 99 (43% BRCA 
mutation carriers, 
57% non-carriers). 
Mean age: 53. 
Ethnicity: Ashkenazi 
Jews. 
Subsample of BRCA 
mutation carriers 
(43%). 
Retrospec-
tive,  
Cross-
sectional 
Assess the effect of genetic 
test results on decisions 
about risk-reducing surgery. 
Evaluate the motivating 
factors for decisions. 
Evaluate satisfaction with 
their decision to undergo 
risk-reducing surgery. 
Self-
administered 
questionnaire 
constructed for 
research. 
Items about demographic 
data, family history, 
genetic test, reasons to opt 
for or reject RRM/RRO, 
attitudes about these 
procedures. 
Genetic test results (BRCA 
mutation carriers v non-
carriers), 
Demographic characteristics, 
Beliefs in the efficacy of 
surveillance strategies. 
94% of BRCA carriers 
considered positively the option 
of RRO.  78% underwent this 
surgery. 
25% of BRCA carriers 
considered positively the option 
of RRM.  19% underwent this 
surgery. 
RRO was more acceptable than 
RRM from an attitudinal and 
practical aspect. 
Lerman et 
al. (2000) 
USA 
n = 216 
Age: 34% 25-39 
years.  66% 40 years 
or older. 
Ethnicity: Caucasian. 
Subsample of BRCA 
mutation carriers 
(n=84). 
Prospective 
Examine prophylactic 
surgery and surveillance 
behavior one year following 
BRCA1/2 gene testing. 
Structured 
telephone 
interviews. 
 
Sociodemographic 
variables, clinical 
variables, Intrusion 
subscale of IES. 
Sociodemographic variables, 
Clinical variables, 
Cancer-specific distress. 
3% of unaffected BRCA mutation 
carriers underwent RRM. 
BRCA mutation carriers had 
significantly higher rates of 
mammography. 
Litton et 
al. (2009) 
USA 
Total n = 312 (BC: n 
= 217.  BRCA: n = 
86). 
Age: not stated. 
BRCA carriers’ 
ethnicity: White=75, 
Hispanic=7, Black=1, 
Asian=2, Other=1. 
Subsample of BRCA 
mutation carriers. 
 Cross-
sectional 
Evaluate opinions about 
screening and surgical 
strategies among women at 
high-risk of BC. 
Postal survey 
developed by 
researchers. 
12 questions regarding 
perceptions of genetic 
testing, screening and risk 
reduction options. 
BRCA mutation status, 
BC, 
Demographic characteristics, 
Views about preventive 
options 
BRCA mutation carriers were 
more likely to believe RRM was 
the best way to reduce risk and 
worry of BC, and more likely to 
proceed with this intervention.   
Lodder et 
al. (2002) 
Nether-
lands 
n = 63 (BRCA: n 
=26) 
Age mean: 
BRCA+RRM=35.4 
BRCA+surveillance= 
42.3 
Non-BRCA=37.4 
Ethnicity: not stated. 
Subsample of BRCA 
mutation carriers 
undergoing RRM 
(n=14) or surveillance 
(n=12). 
Prospective 
Explore decisions of 
BRCA1/2 mutation carriers 
to undergo prophylactic 
surgery or regular 
surveillance. 
Examine their course of 
distress, body image, and 
sexuality. 
Interviews and 
questionnaires. 
 
LOT, 
HADS, 
Symptom Checklist, 
 IES, 
Body image and sexuality 
questionnaire. 
Biographical and pedigree 
information, 
Experiences with cancer in 
relatives, 
Optimism, 
General distress, 
Cancer-related distress, 
Body image and sexuality 
BRCA mutation carriers who 
opted for prophylactic surgery 
had significantly higher distress 
than those who opted for 
surveillance.  They were more 
often in their 30s, more often had 
young children, and had a longer 
awareness of their familial cancer 
risk. 
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Meiser et 
al. (2003) 
Austra-lia 
n = 371 
Age median: 42. 
Age range: 19 – 88. 
Ethnicity: not stated. 
Women unaffected by 
cancer, with unknown 
mutation status, from 
families with 
inherited 
susceptibility to BC. 
Retrospec-
tive,  
Cross-
sectional 
Assessing women’s attitudes 
towards and intention to 
undergo prophylactic 
mastectomy, prophylactic 
oophorectomy, or 
chemoprevention using 
tamoxifen. 
Self-
administered 
questionnaire. 
 
Demographic 
characteristics, 
Objective BC risk, 
LOT, 
HADS, 
IES. 
 
Intention to undergo RRM, 
Intention to undergo RRO, 
Intention to take tamoxifen 
16% of women reported 
considering RRM; 33% had 
considered RRO; 23% reported 
considering tamoxifen. 
O’Neill et 
al. (2010) 
USA 
Total n = 308  
(RRM: n=308.   
RRO: n = 276). 
Age range: 25 – 75. 
Ethnicity (RRM): 
53% Jewish, 47% 
non-Jewish. 
Ethnicity (RRO): 
49% Jewish, 51% 
non-Jewish. 
Women with 
BRCA1/2 mutation or 
with BRCA1/2 
uninformative status. 
Prospective 
Examine the effect of BRCA 
genetic test result on 
perceived pros and cons of 
RRM, RRO and BC 
screening. 
Telephone 
interview. 
Sociodemographics, 
family cancer history, 
psychosocial variables, 
and attitudes toward risk 
management options 
(pros/cons).  
Sociodemographics, 
Medical/Family history, 
Pros/Cons of risk 
management options, 
Intentions for RRM and 
RRO, 
Uptake of RRM and RRO 
BRCA1/2 mutation status 
predicted stronger pros for RRM 
and RRO. 
Pros of surgery predicted RRM 
and RRO intentions in BRCA 
mutation carriers. 
Ray et al. 
(2005) 
USA 
n=62 
Age mean: 51 
Age range: 25 – 80 
Ethnicity: not stated. 
Women at high-risk 
of BC who received 
genetic counselling, 
of which 37% did not 
have BRCA testing. 
Prospective 
Describe uptake of RRM or 
RRO in women at high risk 
for BC and ovarian cancer. 
Investigate if BRCA 
mutation status influences 
decision to undergo risk 
reducing surgery. 
Postal self-
report measure 
developed for 
the study. 
 
Demographic and disease 
characteristics, Risk-
reduction surgery intent, 
Cancer Screening and 
Prevention Checklist. 
Demographic and disease 
characteristics, 
Risk-reducing surgery intent, 
Uptake of risk-reduction 
surgery and surgery 
decisions. 
BRCA test result was most 
important influence for risk-
reducing surgery decisions.   
Reasons for indecision included 
genetic testing results, concerns 
about surgery, timing in life, and 
premature menopause. 
 
Note. USA = United States of America; n = number of participants; C-A = cancer-affected; C-UN = cancer-unaffected; BC = breast cancer; BRCA = breast cancer gene status; RRM = risk reducing mastectomy; CRRM = 
contralateral risk reducing mastectomy; RRO = risk reducing oophorectomy; MRI = magnetic resonance imaging; BSO = bilateral salpingo-oophorectomy; HADS = Hospital Anxiety and Depression Scale; MOS SF-12 = 
Medical Outcomes Study Short Form; IES = Impact of Events Scale; LOT = Life Orientation Test. 
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mutation status of participants, and the preventive options considered and compared by 
participants (RRM, RRO, chemoprevention and/or surveillance).  It is notable that only one 
study (Ray et al., 2005) used an established theoretical model, the Precaution Adoption 
Process model, to guide their investigation.  This highlights an important shortcoming of the 
overall body of research in this area.   
The breast cancer risk management alternatives studied included, in addition to RRM, 
surveillance or screening (Borreani et al., 2014; Claes et al., 2005; Haroun et al., 2011; 
Lerman et al., 2000; Litton et al., 2009; Lodder et al., 2002; O’Neill et al., 2010; Ray et al., 
2005) and chemoprevention using tamoxifen (Meiser et al., 2003).  All studies, with the 
exception of Haroun et al., (2011) investigated breast and ovarian cancer preventive 
alternatives such as RRO and RRSO, as the BRCA positive samples were at increased high 
risk for both types of cancer.   
Two studies reported that the low rates of RRM uptake among participants at high risk 
of breast cancer impeded an analysis of predictive factors (Claes et al., 2005; Lerman et al., 
2000).  Participants in these studies expressed a preference for or engaged in other risk 
management options, including surveillance practices or RRO. 
Predictors of decision to undergo a RRM. A number of possible predictors have been 
explored and reported by the studies included in this review with varied frequencies, such as 
educational level (Kram, Meiser), age (O’Neill, Meiser), BRCA mutation carrier status 
(Kram, O’Neill), or cancer-related distress (Lodder, Meiser).  
Investigating reported intent to undergo risk-reducing surgery and actual uptake, Ray et 
al. (2005) found that there was no statistically significant correlation between these two 
factors with regards to RRM. In a high-quality Australian large-sample study, Meiser et al. 
(2003) reported no association was found between women’s perceived risk of BC and their 
consideration of RRM, despite it being predictive of women’s intentions to take tamoxifen 
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and to undergo RRO.  One plausible explanation offered by the authors was that body image 
preoccupations might represent a stronger predictor of RRM intentions than perceived risk.  
Furthermore, in this study of factors influencing intention to undergo RRM, there were no 
associations between women’s intentions and psychological or family history variables 
considered, which in addition to perceived risk, included age, educational level, 
breast/ovarian cancer distress, optimism, and number of first degree relatives with breast 
cancer. 
Other research has yielded differing results, with BRCA mutation status appearing to 
be a consisted predictor of RRM decisions.  A small subsample of BRCA carriers chose to 
undergo a RRM in the study conducted by Kram et al. (2011).  There were no differences in 
educational level nor in motherhood to young children between women who underwent the 
procedure and those who did not, however finding out about one’s BRCA1/2 mutation carrier 
status impacted on women’s decision-making; among BRCA1/2 mutation carriers there was a 
significant increase in women who considered RRM after receiving their genetic test result. 
Similarly, in their study examining the perceived pros and cons of RRM, RRO and 
breast cancer screening, O’Neill et al. (2010) found that, compared to participants with an 
uninformative BRCA1/2 mutation testing results, women who tested positive reported 
increased perceived pros for RRM, whereas their perceived cons remained unchanged.  The 
pros in this study corresponded with participants’ perceptions of the risk-reducing benefits of 
surgery, such as reduction of the risk of developing breast cancer, of dying from breast cancer 
worry about breast cancer, worry about how their families would be affected, and physician 
recommendations.  The cons pertained primarily to concerns about the risk of surgery, long 
recovery from the surgery, and changes in physical appearance.  Furthermore, this study 
found that stronger RRM pros and weaker cons predicted RRM intentions after women 
received their genetic test result, but only for BRCA1/2 mutation carriers.  Age was found to 
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also be a factor, as was ethnic origin. In this study Ashkenazi Jewish women were 
significantly less likely to report considering RRM as a breast cancer risk management 
option.  Participants under the age of 50 reported stronger pros and cons and weaker 
intentions for all BC risk management alternatives.  
More elevated anxiety and cancer-related distress were found in women with a 
BRCA1/2 mutation status opting for a RRM than in those who were BRCA1/2 mutation 
carriers opting for surveillance and in those who were non-carriers, both before and up to one 
year after receiving the genetic test result (Lodder et al., 2002).  One study, albeit of lower 
methodological quality, differentiated between participants who had been affected by cancer 
and those who had not, reporting that surgical options were taken up more often by cancer-
affected women (Borreani et al., 2014). This group of participants did not report significant 
cancer worry reductions after the surgery, in contrast to cancer unaffected women and despite 
the data showing a significant decrease in their risk perception.  The authors have suggested 
that perceived risk of reoccurrence might be linked to perceived personal risk of breast 
cancer.  Haroun et al. (2011) reported that women who perceived this risk to be greater than 
50% were significantly more likely to opt for RRM instead of MRI surveillance than women 
who perceived their risk to be lower. 
Women’s reasons for deciding to undergo a RRM.  A number of studies, both 
prospective and retrospective, investigated the reasons participants ascribed to their RRM 
uptake decisions.  Genetic testing information, and particularly genetic test results regarding 
BRCA mutation status, was cited as the most influential reason in the decision to have risk-
reducing surgery, followed by information about cancer risk (Ray et al., 2005). 
A significant proportion of BRCA1/2 mutation carriers in Litton et al. (2009) felt that 
they did not find mammograms to be an uncomfortable procedure, yet, compared to non-
carriers, they considered that RRM was the most effective way of reducing the risk of 
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developing breast cancer, and the only way to reduce worry of getting breast cancer.  Despite 
their willingness to undergo regular mammograms and perform self-directed breast 
examinations, the majority of women who expressed those viewpoints opted for a RRM. 
Similarly, investigating factors related to women’s switch from MRI-based surveillance 
to RRM, Haroun et al. (2011) found that dissatisfaction with the screening programme was 
not a motivating factor; rather, women provided other reasons, most commonly fear of 
cancer, fear of dying and of leaving their children behind, and wanting to avoid the 
experience of battling with cancer after their relative(s) had suffered this. 
Women’s reasons for indecision about RRM and for choosing to not undergo a 
RRM.  In five studies of comparable good quality (Claes et al., 2005; Haroun et al., 2011; 
Kram et al., 2006; Lodder et al., 2002; Ray et al., 2005) the reasons for women not opting to 
have RRM were investigated.  Women who were indecisive about risk-reducing surgery in 
Ray et al. (2005) cited reasons summarised in the themes of genetic testing factors (e.g. 
family history versus test results), concern about surgery as a procedure (e.g. fear of having 
surgery, major decision in life, surgery is irreversible, body alterations from surgery), timing 
not being right (e.g. childrearing, finishing chemotherapy, young age).  The main 
disadvantages of RRM indicated by women who opted for breast cancer surveillance in the 
year after their genetic test results, were the ‘negative impact on physical 
appearance/functioning (e.g. scars, mutilation, recovery period), ‘body image’ and ‘negative 
emotional impact’ (Claes et al., 2005). 
Concerns about body image and fear of surgery were also reported by women who 
opted for MRI-based surveillance instead of RRM in the study by Haroun et al. (2011).  
However, they cited their satisfaction with and confidence in screening as their main reason 
for following the MRI surveillance programme and not undergoing RRM.  Similarly, in a 
sample of Israeli women, the belief in the efficacy of surveillance for detecting a tumour at an 
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early stage was negatively correlated with their consideration and uptake of both breast and 
ovarian risk-reducing surgery (Kram et al., 2006).  Additional reasons provided for deciding 
against RRM were the impact of the surgical procedure on femininity, self-image, and body-
image.  Similarly, participants in Lodder et al. (2002) who opted for breast surveillance 
instead of RRM considered they felt sufficiently safe with the surveillance programme, 
whereas others perceived that they either would never opt for an intervention as drastic as 
RRM or that they still had time to reflect on whether they wanted it in the future.  
The findings reported by these studies with regards to women’s reasons for deciding to 
undergo RRM or choosing different risk-management alternatives are echoed in the results 
presented by the qualitative studies included in this literature review. Common themes from 
the qualitative and quantitative studies include the benefits and costs of RRM as appraised by 
participants including body image preoccupations, the acceptability of the surgical procedure, 
perceptions of breast cancer risk, and cancer-related anxiety and distress. 
 
Results of Qualitative Studies 
This review included three studies which employed different qualitative methodologies 
(content analysis, thematic analysis, and grounded theory) and varied in their aims (exploring 
the impact of RRM, the meaning of the surgery, and participants’ conceptualisations of risk 
and risk prevention options), the sample characteristics such as ethnicity and age, and the risk 
management options considered and compared by participants (RRM only, or RRM and 
RRO) (see Table 2), but which were of comparable good quality.  In their cross-sectional 
studies, Hallowell (1998) and Salant et al. (2006) conducted interviews with women in the 
UK and in the USA respectively who were considering their high risk of breast cancer and 
the preventive options available to them.   Kwon and Chu (2012) conducted their 
retrospective study with a sample of Chinese women who had received a contralateral RRM. 
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Table 2.   
Summary of Qualitative Studies  
 
Note. UK = United Kingdom; USA = United States of America; n = number of participants; BC = breast cancer; BRCA = breast cancer gene status; RRM = risk reducing mastectomy; CRRM = contralateral risk reducing 
mastectomy; CPM = contralateral prophylactic mastectomy; RRO = risk reducing oophorectomy. 
Author(s), 
year 
Country Sample 
Sample characteristics 
of interest 
Design Aim(s) 
Data collection 
method 
Methodology Themes Summary of results of interest 
Hallowell 
(1998) 
UK 
n = 41 
Age mean: 40.   
Age range: 22 – 59. 
Ethnicity: not stated. 
BRCA: not stated. 
Women with a 
familial high risk of 
breast or ovarian 
cancer, who did not 
have personal history 
of cancer. 
Cross-
sectional 
Provide insight into 
the meaning of 
prophylactic surgery 
as a risk management 
strategy for women 
with a familial risk of 
BC and OC. 
Semi-structured 
interviews. 
Content 
Analysis 
Perceived benefits of 
prophylactic surgery 
Perceived costs of 
prophylactic surgery. 
Prophylactic surgery provided women 
the means to fulfil their obligations to 
family members and to reduce and 
contain their fear of cancer. 
RRO was more acceptable than RRM, 
influenced by the different physical 
and psychosocial implications. 
Kwong 
& Chu 
(2012) 
Hong 
Kong 
n = 12 
Age mean: 47 
Age range: 34 – 55.   
Ethnicity: Asian 
(Southern Chinese). 
11 BRCA1/2 mutation 
carriers and 1 non-
carrier. 
All had history of BC 
and had elected 
CRRM. 
Retrospective  
Explore the 
experience and 
impact of CRRM 
from Chinese 
females’ subjective 
perspectives. 
Face-to-face or 
telephone 
interview. 
Thematic 
Analysis 
Stage 1: Decision-Making 
Stage 2: Immediate 
impact of CPM 
Stage 3: Chronic impact 
of CPM. 
All participants opted for CRRM due 
to reservations about efficacy of 
surveillance and worries of BC risk. 
Salant et 
al. (2006) 
USA 
n = 33 
Age mean: 55 
Age range: 33 – 77 
Ethnicity: 73% 
African American, 
18% White, 9% 
Other (Hispanic, 
Asian). 
Women without 
personal history of 
BC, at high risk of BC 
and/or moderate to 
high risk of carrying a 
BRCA mutation. 
Cross-
sectional 
Examine women’s 
conceptualisations of 
BC risk and views 
about preventive 
options available to 
them.   
Semi-structured 
interviews. 
Grounded 
Theory 
Breast cancer risk 
perceptions: personal risk 
perceptions; meaning of 
“high risk”; causes of 
breast cancer. 
Breast cancer prevention: 
prevention choices and 
attitudes; gene testing. 
BC screening was welcomed.  
Preventive options were perceived to 
cause problems and were only 
acceptable as treatment options for a 
disease. 
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Meaning of ‘at high risk’ and breast cancer risk perceptions.  Individuals 
considered as ‘at high risk’ perceive their health status in diverse ways (Hallowell et al., 
1998).  These perceptions might be dependent on physical and emotional states.  Salant et 
al.’s study (2006) highlighted that many women, despite their awareness of their hereditary 
risk, did not consider their breast cancer risk status as static or as an objective medical 
description, but rather as fluctuating.  In particular, experiencing physical symptoms made 
the risk of breast cancer more salient to them.  This frequently led women to misestimate 
risk.  All participants of Kwong and Chu’s (2012) study expressed the view that the CRRM 
had decreased their risk of future breast cancer, but they overestimated this risk even after the 
procedure.  The different interpretations of both the designation of ‘at high risk’ and of 
changes in perceived risk may, in turn, influence women’s perceptions of risk management 
alternatives. 
Relief from fear, worry and risk.  RRM afforded women relief from their breast 
cancer worry and fear (Hallowell, 1998; Kwong & Chu, 2012).  As expressed by a participant 
who had underwent CPM: “I can finally stop worrying whether the doctor would find a lump 
again and start living a normal life!” (Kwong & Chu, 2012, p.2245).  In contrast, for the 
participants in Salant et al.’s (2006) study, the relief of fear or worry was not sought from 
risk-reducing nor early detection strategies.  Instead, participants’ understanding of risk as a 
physical symptom requiring medical intervention and their idiosyncratic breast cancer 
causality beliefs were linked to cognitive avoidance strategies, such as “not dwelling on it” 
and “not thinking about it”.  Coping with the fear or threat of cancer was achieved by means 
of prayer, spiritual healing and spiritual statements of acceptance, e.g.  “what happens, 
happens”. 
Relationships and self.  The influence and importance of women’s relationships with 
other people and of women’s self-perceptions are salient in two of the studies (Hallowell, 
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1998; Kwong & Chu, 2012).  Women considering RRM or RRO (Hallowell, 1998) referred 
to these options in terms of their ‘benefits’ and ‘costs’ pertaining to the impact they would 
have upon their relationships.  For example, surgery was seen by some participants as 
enabling them to fulfil their duties of care towards their children and families, whereas other 
women viewed surgery as an obstacle to being able to fulfil their social, work, and familial 
roles.  The influence of their relationships with others in the case of Kwong and Chu’s (2012) 
cohort of participants extended to the decision-making for some women, who involved their 
families in their decision.   
Issues of personal and interpersonal identities were also linked to women’s views of the 
acceptability of the surgical preventive options.  RRM was seen as altering their body image 
to a greater extent than RRO and was therefore less acceptable in Hallowell’s study (1998), 
due to the body changes being potentially more visible and breasts being fundamental to their 
body image.  As one 25-year-old women expressed: “Your boobs you can see, and if my 
ovaries are still there or not makes no difference, because nobody else can see them” (p.270).  
For the participants interviewed by Kwong and Chu’s research (2012), cosmetic concerns and 
impact on sexuality were not identified as important factors in their CPM decision-making.  
However, following the procedure, those who were in relationships were sensitive to their 
spouses’ reactions and attitudes, and whether the CPM affected their sexual relationships.  
This echoes findings in Hallowell’s (1998) paper, as some participants had expressed worry 
that having a RRM would impact their sexual relationships by making them appear less 
attractive. 
Differences between risk-reducing options.  Women held different views and 
attitudes about the risk-reducing options available to them and/or which they chose to engage 
in.  Some women were not interested or were uncertain about taking medication such as 
tamoxifen, citing reasons such as reluctance to take pills, fearing harmful side effects, or the 
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lack of guarantee that it can inhibit breast cancer (Salant et al., 2006).  Participants in Kwong 
and Chu’s (2012) study reported that mammographic surveillance was not as effective in 
relieving the fear and worry that was induced by their BRCA1/2 mutation status; despite 
being a non-invasive option, it was perceived as a stressful recurrent reminder of their 
heightened risk of breast cancer: “Surveillance was neither inconvenient nor painful but it 
was a periodic reminder that I was carrying a cancer bomb… physically surveillance may 
seem non-invasive but psychological it was difficult (to deal with)” [sic] (p.2243).  The 
authors highlighted that participants’ prior experience of breast cancer treatment might have 
influenced their “pleas for a more efficacious treatment, if not closure” (p.2245).  Women 
considering the options of RRM or RRO in Hallowell’s study (1998) regarded the latter as a 
more acceptable alternative due to the different psychosocial and physical implications of the 
procedure: RRO was seen as precipitating changes which would be less visible and which 
would occur naturally if no surgery was had (i.e.  menopause), and ovaries were not seen by 
participants as constituting a public representation of their femininity. 
 
Discussion 
 The aim of this paper was to review the existing literature examining women’s views 
of RRM when they are considering breast cancer risk management alternatives due to being 
at high risk of developing this illness.  Additionally, this mixed-methods systematic review 
examined what are the predictors of women’s RRM decisions and how they make decisions 
about this surgery when they are considering at least one other risk management alternative.   
Overall, the findings suggest a range of factors might be relevant to, and predictive of, 
women’s RRM uptake decisions when they are considering several breast cancer risk-
reduction or early detection options.  These factors include perceived risk of breast cancer or 
of recurrence of breast cancer, BRCA1/2 mutation status, cancer-related worry or fear, and 
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satisfaction with and confidence in other methods.  Framed within relevant models for health 
prevention decision-making, the findings of this review are in line with, and advance, those 
reported by Howard, Balneaves, & Botorff (2009) and by Fielden et al.’s (2017) synthesis of 
qualitative research.  The predictive value of demographic variables such as age, educational 
level, or ethnicity have not been adequately explored due to heterogeneity of samples and low 
rates of RRM uptake in several studies.   
Genetic testing and, more specifically, the result of BRCA1/2 mutation status, was 
highlighted in some studies as the most influential factor in women’s decisions to undergo 
risk-reducing surgery, which has been reported in other studies (Scheuer et al., 2002).  
Additionally, high levels of cancer-related worry, fear, or distress in women opting for RRM 
have been observed in previous research (Meiser et al., 2000; Stefanek, Helzlsouer, Wilcox, 
& Houn, 1995), as has been a longstanding awareness of being at increased risk, which 
decrease significantly after they undergo RRM. 
Differences in people’s attitudes and preferences for breast cancer prophylactic surgery 
or other risk-management measures have been explained by cultural differences, both for 
women and health care professionals (Julian-Reynier et al., 2001).  The findings of individual 
studies included this review have not emphasized cultural or social differences as predictors 
or influences of women’s RRM decisions. However, among the included studies there appear 
to be variations in participants’ preferences and attitudes towards breast cancer risk 
management options.  In line with what has been highlighted by recent research (Wainberg & 
Husted, 2004), it is possible that these differences could also be attributed to the variations of 
cultural norms, to the differences in breast cancer counselling protocols between countries, 
and to variation in the availability of risk-reducing options (Metcalfe et al., 2008); the effects 
of these cultural differences on people’s views of RRM are yet to be fully understood. 
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Additionally, women’s views and attitudes about RRM relevant to their decisions when 
they are considering more than one breast cancer risk-reduction option are reflected on the 
reasons why they would or would not opt for this strategy.  The findings suggest that both 
perceived effects on body image and sexuality, and perceived confidence in other early 
detection or other preventive methods were associated with women’s preferences.  Due to 
this review including studies of women considering RRM and at least one other risk 
management or early detection alternative, it has been possible to gain some insight into the 
comparisons made between these.  Other possible factors, such as fear of undergoing a 
surgical procedure, remain to be adequately investigated in future research. 
With regards to body image and sexuality, some studies proposed these factors as 
influencing women’s views of RRM and its acceptability.  There is evidence that this type of 
prophylactic surgery can impact individuals’ body image and intimate relationships, although 
often these issues are not considered a priority nor addressed before the surgery; negative 
effects on body image and sexual or marital problems are common difficulties after the 
surgery (Bebbington & Fallowfield., 2003; McGaughey, 2006).  With regards to confidence 
in other preventive or early detection measures, it could be hypothesised that women may not 
opt for RRM if they perceive surveillance, chemoprevention and/or RRSO as effective 
measures which address their perceived risk of breast cancer and the psychological 
consequences of being at high risk of this illness, such as fear, worry or distress. 
A range of theoretical models have emphasized the role and relevance of cognitive 
variables in the uptake of health-related behaviours, including preventive options among 
individuals at increased risk of breast cancer (Cohen, 2002; Decruyenaere, Evers-Kiebooms, 
Welkenhuysen, Denayer, & Claes, 2000).  In this review of the literature, only one study 
(Ray et al., 2005) applied an explicit theoretical model, namely the Precaution Adoption 
Process (Weinstein & Sandman, 2002), according to which the uptake or risk-reduction 
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surgery requires deliberate action in seven distinct stages.  Other models and heuristics could 
have informed the studies and appear to be relevant to the findings, yet have not been applied 
in this specific area of research to date.  For example, when considering women’s views of 
RRM, it could be hypothesised that from the perspective of the ELM, individuals might 
process highly emotive, personally relevant, and complex cancer-related information via the 
peripheral route, thus being likely to rely on social influence and heuristics.  Research 
indicates that breast cancer risk perceptions are influenced by several types of heuristics 
(Facione, 2002; Katapodi et al., 2004; Rees et al., 2001).  Therefore, consideration should 
also be given to whether and how people’s views on, and decisions about, RRM are similarly 
constructed relying on heuristics.  It could be posited that, in addition to breast cancer risk 
perception, other possible RRM uptake predictors such as cancer-related distress or impact on 
physical appearance might be influenced by heuristics such as availability, simulation, or 
affect heuristics.  Future investigations addressing this gap in understanding should be 
considered. 
A study quality appraisal was conducted using a well-developed instrument (QATSDD; 
Sirriyeh et al., 2012).  This quality assessment pointed to inconsistencies in information 
reporting across studies with regards to study design, sample characteristics, data collection, 
or psychometric properties of the measures used (Appendix C).  Using this instrument, it was 
possible to conclude that the majority of the studies were considered to be of adequate quality 
but with notable shortcomings associated with study designs.  This, in conjunction to the 
small number of studies included, demonstrates that this area of research is currently 
understudied, highlighting the important need to conduct further research of greater quality in 
order to develop the knowledgebase. 
The main research designs used across studies, namely prospective studies 
investigating RRM uptake and retrospective reports about RRM decision-making, are not 
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without limitations, such as requiring long durations for follow-up (Song & Chung, 2010) or 
be subject to recall or hindsight biases (Guilbaut et al., 2004), to name a few.  Longitudinal 
designs spanned a maximum of 15 months after BRCA1/2 test results were disclosed, 
therefore it would be of interest to conduct longer studies to explore women’s views of RRM 
and their decisions regarding risk management options over time. 
The great variability among the characteristics of study samples and numbers of 
participants limited the comparability across studies.  The range of psychometric tools used 
to measure anxiety, mood, or cancer-specific distress, and the lack of information regarding 
the validity of these measures also limit comparability.  In addition, the majority of studies 
relied on self-report measures, which are vulnerable to biases such as social desirability; 
therefore, it would be important that future studies utilise additional means of data collection 
and methodologies, including in-depth interviews or broader qualitative methods. 
Furthermore, the majority of hypothesised predictors and factors influencing women’s 
RRM decision-making were explored by only a small number of the included studies.  
Therefore, caution should be exercised in the interpretation of results and with regards to the 
conclusions here drawn.  The possibility that views about RRM, intention to undergo RRM, 
and actual uptake of RRM could be better predicted by other factors or combinations of other 
factors should not be excluded.  Thus, on the matters here investigated, the existing research 
offers valuable information but the results cannot be considered conclusive, for the reasons 
outlined above. 
 
Strengths and Limitations 
There are several limitations to this review.  Firstly, the inclusion of studies which 
differed greatly with regards to design and participant samples, conducted in countries with 
notable cultural differences, makes it difficult to draw general conclusions.  Secondly, 
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although the inclusion criteria incorporated studies published in languages other than English, 
some studies might have been missed due to the data search being conducted with English 
keywords under the premise that studies published in other languages often include a 
translated title, abstract and keywords.  Thirdly, there might be a risk of reporting bias, since 
this review focused on articles published in peer-reviewed journals and, therefore, potentially 
relevant research such as grey literature has not been included. 
Additionally, articles retrieved via the database searches were reviewed for inclusion by 
one researcher (ESN); therefore, there is a possible risk of bias in the screening and selection 
process.  However, a research supervisor (SB) was consulted multiple times during this 
process of screening and selection. 
The inclusion of both qualitative and quantitative research constitutes a strength of this 
review.  Nevertheless, quantitative research with a priori hypotheses about how people think 
may have failed to capture in-depth personal experiences (Smith, Flowers & Larkin, 2009).  
This shortcoming might have not been adequately supplemented due to the low number of 
qualitative studies included. 
 
Clinical and Research Implications 
The findings of this review, despite indicating an overall paucity of conclusive 
evidence, are of preliminary relevance for clinicians working with women at increased risk of 
breast cancer who are contemplating risk-reducing surgery.  The results presented in this 
literature review suggest that a range of personal, social and cultural factors might influence 
women’s views of RRM and might predict their decisions to undergo RRM, as has also been 
evidenced elsewhere (British Psychological Society’s Division of Clinical Psychology 
Faculty for Oncology and Palliative Care, 2017).  This suggests that clinicians’ understanding 
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of these variables, as well as of heuristically-led decision-making processes, might help 
improve patients’ experiences of RRM deliberation.   !
Nevertheless, a lot remains to be understood about the optimal management of breast 
cancer risk for women at high risk of this illness, and continuous evaluation of the 
effectiveness and psychological impact of the available risk-reducing options is necessary 
(Bermejo-Perez, Marquez-Calderon, & Llanos-Mendez, 2007).  Equally, numerous questions 
remain unanswered regarding the psychosocial variables that predict and influence women’s 
RRM decisions, for the current evidence can be considered promising but emergent.  It is, 
therefore, recognised that a more in-depth understanding of the predictors of RRM uptake 
and of women’s views of this surgery is required in order for future findings to inform and to 
be embedded in breast cancer psychosocial care and decision-making support for women at 
increased risk of breast cancer.   
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Abstract 
Risk-Reducing Mastectomy (RRM) is the surgical removal of breast tissue to reduce breast 
cancer risk.  However, it is non-reversible and can be associated with iatrogenic effects.  
Existing evidence suggests that patients at high risk of breast cancer make RRM decisions 
driven by fear of the illness.  This study aimed to gain a further understanding of patient’s 
views about RRM and about how they reach their decision to undergo it.  Using a qualitative 
research design, seven participants were interviewed.  Results suggest that patients made 
their decision to have a RRM in an immediate, non-hesitant manner.  They were not able to 
describe those decisional processes in detail, but engaged in post-decisional reviewing 
processes.  Participants’ views of RRM as the best option for them were linked to their 
motivation to avoid future illness and treatment, to the sense of relief and safety that their 
choice provided them, and to the perception of doing something proactive to gain control.  
These finding are considered in the context of decision-making theory, as they highlight that 
patients who are at high risk of breast cancer might reach RRM decisions heuristically, 
guided by emotion.  Strengths and limitations of this study are considered, and further 
avenues of investigation are proposed.   
 
Keywords: breast cancer, risk-reducing mastectomy, decision-making, qualitative research. 
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Introduction 
Breast cancer (BC), which affects primarily females, has been the most common cancer 
in the United Kingdom (UK) since 1997, and it accounts for 31% of all new cases of cancer 
in women (Cancer Research UK, 2015).  In 2015 a total of 46,083 cases of breast cancer 
were registered in England, 45,764 of which were for females (Office for National Statistics, 
2017).  Both the disease and its treatment can result in long-term physical and psychological 
consequences, including adverse impacts on quality of life, body image, self-perceptions of 
femininity, pain or fatigue (Campora et al., 1992; Pasacreta, 1997). 
Prognostic improvements in the field of cancer care mean that, increasingly, it is 
possible to identify whether women are at heightened risk of breast cancer (Rosenthal et al., 
2017).  Family history of breast cancer confers increased risk; the risk of women with an 
affected first-degree relative is approximately twice than that of women with no first-degree 
relatives (Cancer Research UK, 2014).  The risk increases with larger numbers of affected 
first-degree relatives, or relatives with the disease under the age of 50 (Cancer Research UK, 
2014).  Genetic risk is mainly mediated by mutations in the BRCA1, BRCA2, P53 and 
CHEK2 genes, which confer increased risk of developing breast and ovarian cancer (National 
Institute of Health and Clinical Excellence [NICE], 2013).  In the UK genetic testing for 
breast cancer susceptibility is available for breast cancer patients based on family history of 
early onset of breast or ovarian cancer, and for relatives of patients with a known inherited 
genetic mutation (NICE, 2013).   
Early detection and risk-reducing options are available for women who are identified as 
at increased familial risk of breast cancer; these include lifestyle changes such as weight loss 
or alcohol reduction and smoking cessation, screening with MRI and mammographic 
surveillance, chemoprevention with selective estrogen receptor modulators, and risk-reducing 
breast or ovarian surgery (NICE, 2013).  Risk-reducing mastectomies (RRM) are 
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prophylactic options that involve the surgical removal of healthy breast tissue with the aim of 
reducing the risk of suffering breast cancer (NICE, 2013).  RMM can be performed 
contralaterally (CRRM) in the opposite breast to one already removed during treatment 
mastectomy in patients who have experienced breast cancer, or bilaterally (BRRM) in both 
breasts.  With this procedure a residual risk of developing breast cancer remains (Lopez & 
Porter, 1996; Willemsem, Kaas, Pertese, & Rutgers, 1998). 
Recent studies have reported an increasing trend in the uptake of RRM both for cancer 
affected and unaffected women (Balch & Jacobs, 2009; Tracy, Rosenberg, Dominici, & 
Partridge, 2013).  RRM reduces the risk of breast cancer occurrence for women at high risk 
(Evans et al., 2013; Metcalfe et al., 2014) and improves the life expectancy of women with 
genetic mutations (Lostumbo, Carbine, Wallace, Ezzo, & Dickersin, 2004).  Despite CRRM 
reducing the incidence of contralateral breast cancer by 90% (Tuttle, Habermann, Grund, 
Moris, & Virnig, 2007), this is not associated with an increased survival benefit unless 
women have a genetic mutation (Lostumbo et al., 2004).  Furthermore, RRM is irreversible 
and can have negative outcomes, such as post-operative complications, cosmesis and 
concerns about body image (Altschuler et al., 2008; Geiger et al., 2006).  Whilst the majority 
of women report satisfaction with their decision to have a RRM, evidence suggests that 
between 14% and 19% of women might regret their decision to undertake a RRM (Frost et 
al., 2000; Frost et al., 2011). 
 
Decision-Making Regarding RRM 
Current practice and policy regarding medical decision-making emphasize the 
importance of respecting patients’ preferences and of integrating these with clinical evidence 
in the process of shared decision-making (Broadstock & Michie, 2000; Coulter & Collins, 
2011).  This requires informed consent, whereby patients understand and evaluate 
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information about options, probabilities, and their preferences to reach decisions. However, 
patients do not necessarily deliberate about health care decisions having sufficiently 
understood clinical issues, risks or benefits (Mendick, Young, Holcombe, & Salmon., 2010).  
A recent study by Beesley, Holcombe, Brown and Salmon (2013) found that women’s 
decisions to undergo RRM were driven by a sense of vulnerability and by their awareness of 
an existing risk.  Indeed, evidence suggests an association between distress, worry and 
anxiety, and higher rates of RRM uptake (Antill et al., 2006; Madalinksa et al., 2007; van 
Dijk et al., 2003). Furthermore, Brown et al. (2017) reported that women’s decisions to seek 
RRM were motivated by fear of breast cancer and by feeling that they needed to do all they 
could to prevent it.  These findings are consistent with evidence that patients seeking RRM 
do not necessarily consider objective risks and benefits as a primary reason for doing so 
(Beesley et al., 2013).   
Emotion plays an important role in decision-making and in decisional processes 
(Loewenstein, Weber, Hsee, & Welch, 2001; Slovic, Finucane, Peters, & MacGregor., 2004).  
Existing evidence strongly indicates that individuals’ emotional interpretations of information 
influence how they make health decisions, for instance by means of heuristics facilitating 
their information processing and judgement (Kahneman, Slovic, & Tversky, 1982; Lerner & 
Keltner, 2001; Pravettoni, Gorini, Bonanni, Varonesi, 2013; Reyna, 2004).  Incorporating 
both pre- and post-decisional processes, the Differentiation and Consolidation theory 
proposed by Svenson (Svenson, 1992) postulates that the aim of a decision process is to reach 
an outcome or select an alternative that is sufficiently superior in comparison to other 
solutions (differentiation).  Following the decision, post-decisional processes work both to 
consolidate the chosen alternative and to minimise regret threating the choice (consolidation).  
This model incorporates the effects of affect and emotion in human decision processes.   
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Existing research investigating RRM uptake has focused on women’s risk perceptions 
and their decision-making processes.  However, little is known about how women perceive 
and think about RRM procedures, nor about what it is about RRM that qualifies it as a 
convincing option despite its inherent risks and/or despite other risk-reducing or surveillance 
alternatives being available.  Furthermore, as evidenced by existing findings, for some 
women there might be potential disadvantages to making this health-related decision in the 
ways described above.  This study aims to explore women’s views about RRM when making 
RRM decisions, their decision-making process, and the factors influencing this risk-reducing 
procedure becoming the chosen option for women who are at high risk of breast cancer.  
Research in this area has the potential to help both women at risk of breast cancer and 
professionals providing decision support for women facing RRM decisions, by encouraging a 
broader consideration of factors to aid the decision-making process. 
 
Method 
Sampling and Participants 
Ethical approval for the study was obtained from the National Research Ethics Service 
(REC: 13/NW/0421), with recruitment taking place at the Liverpool Cancer Psychology 
Service.  Participants were recruited among women who attended a specialist psychological 
consultation to assess their decision-making regarding RRM and had reached a decision to 
have a RRM; this included recruiting women post-surgery.  Patients were excluded if they 
were under 18 years old, if they were not fluent in English, if they were unsure about RRM, 
or if their care team considered they may not be able to provide informed consent. 
Two recruitment strategies were followed in parallel.  Firstly, initial study information 
was provided by a clinical psychologist who had completed a psychological assessment for 
RRM with the patient, including an information sheet (Appendix D); those interested in 
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participating consented to their contact details to be shared with the researcher, whom 
subsequently contacted them by telephone to further explain the study. Secondly, in order to 
maximize recruitment, letters with the information sheet were posted to patients who had 
attended the service in the previous 18 months, inviting them to take part in the research 
(Appendix E).  A total of 15 letters were sent, with four patients responding and agreeing to 
take part in the study (see Appendix F for participant consent forms).  A sample of seven 
women was recruited; this sample reflected the range of women accessing psychological 
assessments related to RRM procedures, with variation in type of surgery (CRRM or 
BRRM), personal and familial history of breast cancer, genetic mutation status, and 
sociodemographic characteristics.  Participants were interviewed by the researcher at a 
convenient date and location.  Further study details are resented in Appendix G. 
 
Data Collection 
Semi-structured face-to-face interviews (median duration: 49 minutes; range 41 – 67 
minutes) were conducted by ESN.  Participants completed a brief demographic information 
sheet (Appendix H) in order to characterise the sample. 
Interviews were conversational, with open ended questions, prompts and reflections to 
facilitate the exploration of women’s views.  The researcher adopted a non-directive, non-
judgmental approach.  The interviews were semi-structured following a topic guide, which 
was progressively refined as the analysis proceeded (Appendix I).  The initial topic guide was 
developed drawing from previous findings from the wider study (Brown et al., 2017).   
The study had a data protection protocol (Appendix J) and a protocol to be followed if 
women experienced distress (Appendix K); its use was not required.  Participants had the 
option of receiving a summary of findings, with 6 women requesting this information 
(Appendix L).  Interviews were digitally audio-recorded, transcribed verbatim, and 
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anonymised.  The researcher transcribed the initial two interviews with the aim of becoming 
familiar with the data.  A university approved transcriber was employed for the subsequent 
interviews, with the researchers providing clear guidelines (Appendix M) and checking the 
transcripts for accuracy.   
Data Analysis 
In order to engage critically and creatively with the data, and to overcome the 
limitations of flexibility associated with ‘branded’ methodological approaches, whilst 
maintaining creativity and rigour, a pragmatic data analysis approach was followed.  Similar 
approaches have been advocated by qualitative researchers recently (Frost et al., 2011; Gwyn, 
2002; Wright, Holcombe, & Salmon, 2004).  Data were analysed using a pluralist qualitative 
methodology, whereby the researchers adopted a flexible stance to the methods and 
epistemological positions, as required by the data and by the emerging analysis (see 
Appendix L for further information). 
Data analysis took place in parallel with data collection.  As part of the iterative 
process, interview transcripts were read and re-read sequentially by the research team, and 
discussed in regular research meetings.  Brief narratives of the salient features of every 
interview were developed to aid remembering and reflection (Appendix O).  The 
aforementioned discussions informed the ongoing analysis and data collection.  Findings 
were further refined and tested in the research meetings by ‘cycling’ between the emerging 
analysis and new data. 
The iterative data analysis commenced at a descriptive level, as the research team 
developed and defined broad analytic categories illustrating recurring features of women’s 
accounts that were relevant to the study objectives.  These categories were explored in further 
depth in a subsequent interpretive level of analysis drawing from interpretive analysis and 
discourse approaches in order to describe and understand the content, meaning and function 
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of the data in the context of the whole interview, of other interviews, and of the wider social 
settings where women engaged in their RRM decision-making.  Although analysis was 
shaped by commonalities between participants and across the data, attention was also paid to 
heterogeneity and divergence.  In this respect, contradictions to the emerging analysis and 
pivotal cases were recurrently discussed.  Disagreements between researchers during the data 
analysis were encouraged and resolved through discussions.  With the aim of producing a 
detailed and reflective description of the analytic process, summaries and an analytic record 
of the steps taken were produced (see Appendices P and Q).  The quality of the developing 
analysis was assessed against standards of validity, including theoretical and catalytic validity 
(Kincheloe & McLaren, 2000) and trustworthiness (Guba, 1981; Shenton, 2004), as 
explained in Appendix L. 
 
 Results 
Sample Characteristics 
Participant’s demographic information is presented in Table 1.  Participants ranged in 
age from 31-70 years and had varied educational backgrounds, with the lowest education 
level being GCSE or equivalent, and the highest being postgraduate degrees.  Two 
participants were retired and seven were working part-time.  Two of the three women who 
opted for BRRM did not have a personal history of breast cancer, whilst the four participants 
who opted for CRRM had personal histories of breast cancer.  Five participants were 
interviewed prior to the surgical procedure, and they were on a waiting list for RRM. Two 
participants (Participant 4 and Participant 6) were interviewed after having RRM, and both 
expressed being satisfied with the outcome.  Five participants had a family history of breast 
cancer, and five had a family history of other cancers.  Two women had a BRCA1/2 genetic 
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mutation, one had a CHEK2 genetic mutation, two participants were BRCA1/2 negative, and 
the genetic mutation status was unknown for two participants.   
 
Table 1 
Participant Demographic Information 
ID Age 
BC 
hist
ory 
Time 
since 
BC 
diagno
sis 
Other 
cancer 
history 
Family 
BC 
history 
Family 
history 
of other 
cancers 
Genetic 
testing 
status 
RRM 
Inter-
viewed 
pre or 
post 
RRM 
Highest 
education 
level 
Work 
status 
1 46-50 Yes 
20 
months 
No Yes Yes Negative CRRM Pre 
GCSE or 
equivalent 
Part-
time 
2 56-60 Yes 
108 
months 
No Yes No Un-known BRRM Pre 
A-levels or 
equivalent 
Retired 
3 56-60 No N/A No Yes Yes 
BRCA1/2 
Positive 
BRRM Pre Postgraduate Retired 
4 66-70 Yes 48 
months 
No No Yes Negative CRRM Post GCSE or 
equivalent 
Part-
time 
5 46-50 Yes 
29 
months 
Yes No No 
CHEK2 
positive 
CRRM Pre Postgraduate 
Part-
time 
6 31-35 No N/A No Yes Yes 
BRCA1/2 
Positive 
BRRM Post Postgraduate 
Part-
time 
7 46-50 Yes 
12 
months No Yes Yes Un-known CRRM Pre 
Bachelor’s 
degree 
Part-
time 
Note. ID = Participant identification number; BC = Breast cancer; RRM = Risk Reducing Mastectomy; 
CRRM = Contralateral Risk Reducing Mastectomy; BRRM = Bilateral Risk Reducing Mastectomy; 
BRCA1/2 and CHEK2 = Breast cancer susceptibility genes; GCSE = General Certificate of Secondary 
Education; A-Level = General Certificate of Education Advanced Level (secondary school qualification). 
 
Overview of Findings 
Women’s views about RRM and the ways in which they made their decision were 
remarkably homogenous in important respects, despite the wide-ranging ways in which they 
first become aware of RRM and regardless of their diverse personal histories.  Women made 
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their decision to undergo RRM immediately and generally without prior consideration, but 
when asked were not able to describe their decision-making in detail.  Their views of RRM 
were associated with a sense of safety and relief and using the decision to gain control over 
their lives. A posteriori, they continuously elaborated on these and other reasons for their 
choice, in a process of post-decisional reviewing and justification.   
 
Table 2  
Summary of Findings 
Main categories Sub-categories 
Before the decision 
“I don’t want to go through any of that (again)” 
Finding out about RRM and initial reactions  
The decision “So it was just immediate that I made that decision”  
After the decision – 
Reasons for RRM 
Relief and safety 
“This is my doing something”: Taking action, taking control 
After the decision – 
Reviewing 
Post-decisional reviewing and processing 
 
Before the decision 
Participants spoke of personal or familial experiences of cancer that had affected them. 
They also detailed how they had first learned about RRM.  Most participants knew about 
RRM before being in the position of making their decision. 
“I don’t want to go through any of that (again)”.  All women had experienced cancer 
up close; some had personal recent experience of the illness and its treatment, whilst others 
had witnessed its impact having cared for relatives or friends who had developed it: “And I’ve 
RRM PERCEPTIONS AND DECISION-MAKING AMONG WOMEN AT HIGH RISK OF BC 
! 56 
lost my mum and my brother to cancer.  And it’s, it’s just too raw, so I wanted to do 
everything in my power… to survive” (Participant 1)3.  Their recollections of the experiences 
of those who had passed away from breast cancer or other cancers were salient in their 
accounts of their decisions to have a RRM: “(…) she [friend] actually died in November, so 
watching her deteriorate just made me even more determined to not be in that situation 
really” (Participant 3).  Some women described the increased awareness that they had about 
the pervasiveness and morbidity of cancer due to their contact with people with it, be it 
through their personal lives or through their jobs: “(…) my granddad got lung cancer and 
died (…)  and my auntie had lung cancer and she died at 47, so I might have like a 
hyperawareness of cancer and I’m hyper-frightened” (Participant 6).   
Those who had undergone treatment for cancer, such as chemotherapy or radiotherapy, 
also recollected this experience as difficult and undesirable, and one which they wished to 
avoid: “So I went through everything and then as I got better and got over it and I thought - I 
don’t want to do that again.  I don’t want to go for chemotherapy, I don’t want to lose my 
hair” (Participant 4).  For some participants this extended to the effect that their illness and 
treatment had had on their families as well as on themselves: “The thought of me having more 
chemotherapy, because I know my kidneys wouldn’t hold out for anymore because they’re not 
great at the moment anyway, and the fact that, you know, I wouldn’t like to put my family 
through all that again” (Participant 5).  As highlighted in this quote, their motivation to avoid 
future disease and treatment constituted a strong reason why they decided to opt for RRM, 
and for many was related to their desire to protect their loved ones from that too.    
Finding out about RRM and initial reactions.  Participants recounted different ways 
of learning about RRM.  This variability pertained to both the means by which they first 
found out about RRM and to variations in how well remembered these occasions were, from a 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
3 Ellipses denote pauses in speech. Bracketed ellipses indicate text has been omitted. 
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vague sense of having known about it to a salient memorable moment. The latter was the case 
of Participant 4 when she was about to undergo surgery for breast cancer: “The morning I was 
going in for my surgery there was a lady came in and, as you do, you sit and you talk, and she 
was having both breasts off and I said to her ‘why are you doing that?’ so she said ‘well, it’s 
only in one’ but she said ‘I’m not taking the chance’”. 
Several women found out about the procedure from other breast cancer patients, some 
of whom were family members: “We knew that she [aunt] was going to have obviously the 
other one [breast] removed, and from there really (Participant 6).  Other participants recalled 
hearing about RRM via the media, their responses to which were variable, including praising 
the widely publicised decision of a celebrity: “Through the media probably, and Angelina 
Jolie, and her having it, that was the first one that I’d heard [about] (….) It’s just that, you 
know, she spoke about it publicly, and that she was quite brave and positive”.  Participant 2 
also reported: “It was just something I read, absorbed it, put it at the back of my mind, and 
didn’t really discuss it any further at that point”, reflecting the little relevance that RRM had 
to participants at the time when they first found out about it. 
 
The decision 
Decisions were instantaneous in all cases and participants had little insight into how 
they made them, although one woman (Participant 3) had considered the decision 
hypothetically.  
“So it was just immediate that I made that decision”.  In their reflections about their 
election to have a RRM, almost all women described an apparently instantaneous decision 
that required no deliberation, as is evidenced in Participant 1’s account: “It wasn’t a hard 
decision.  As soon as I was diagnosed I knew, while the consultant was talking to me, what I 
was going to do (…) It was really strange, my sister is next to me crying her eyes out, and I 
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was really straight-faced, just staring at the consultant while she’s explaining to me erm and 
all I kept thinking about was ‘take the other one off, take the other one off’, so it was just 
immediate that I made that decision”.  Accounts such as those of Participants 6, who knew 
that she wanted to have a BRRM at the time of finding out about her genetic high risk of 
breast cancer, illustrate the sense of urgency with which the decision was reached: “She 
[genetics doctor] said ‘your risk is 80%’, at which point I said ‘just get them off as fast as you 
can’.  There was no… there was no ‘but I feel sad’.  Because I just thought, I’m… just… 
quick.  Just as quick as you can”.  
An exception was Participant 3, who had thought about RRM because through her job 
as a radiographer working with breast cancer patients she had considered that decision in 
hypothetical terms in the past: “It’s always been in the back of my mind, all these years when 
I’ve been [working with] ladies who’ve had breast cancer and I’ve always thought that if I 
was in that situation I would want to be rid of my whole breast, get rid of the lot.  I wouldn’t 
want a lumpectomy or anything.  So I’ve always had that feeling in the back of my mind.  So 
then when I got into, not the same situation obviously, but a way of preventing me being in 
that situation, it was fairly straightforward for me.  It’s always been my frame of mind 
anyway.” (Participant 3).   
Women’s accounts denoted their certainty about their decision, and they recalled the 
moment when they reached it as well as how certain they were about their choice, yet 
attempts to expand on that particular moment through means of interview questions were not 
successful:  
-! Participant 5: “When I found out I did have breast cancer and I knew I was going 
to have surgery on this left breast I did say to the consultant ‘Can you just take the 
two of them off?’ and he said ‘It’s not as easy that.  We need to concentrate on the 
side that’s got the cancer first and then obviously after that we’ll chat about…’, so 
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I sort of researched it myself.  When I say researched, just had a little look about 
different forums on the internet and things people had chosen to do really” 
-! (…)  
-! Q: “And do you remember at the time, so obviously, you know, before you spoke 
with the consultant and everything, do you remember what you thought about it 
[RRM]?” 
-! Participant 5: “I’d made me mind up before I’d spoken to him.” 
-! Q: “Had you, yeah?” 
-! Participant 5: “Definitely … I definitely wanted the other breast off.  I definitely 
wanted a risk-reducing mastectomy.” 
-! […] 
-! Q: “Why do you think it was such, you know, such an easy decision for you?” 
-! Participant 5: “I don’t know.  I just thought to myself - I’ve made my mind up and 
that’s what I want doing” 
Despite interviewing efforts to explore how they made their decision to opt for RRM, 
women were not able to expand on this in detail, more often describing their main motives for 
it or their memory of when they reached their decision instead: 
-! Q: I just wondered how, if you can explain to me more - it might be difficult to put it in 
to words - but how did you come up with that decision, if that makes sense? 
-! Participant 7: Because I’m a cautious person. 
[…] 
-! Q: Do you remember how it became like your decision? 
-! Participant 7: Well after they told … the first … when they told me and they did the 
tests but they hadn’t said it’s cancer yet, but I was having those tests … yeah … and I 
had to wait 10 days and I went back home and we sat and I was talking to my husband 
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and I said to him, I said ‘I don’t want them to do a lumpectomy.  I just want it taken 
away now’, and it was then.  It was before I found out it was cancer.   
 
After the decision – Reasons for RRM 
Women described that with their RRM decision they gained relief and perceptions of 
safety and control.  These were advanced as reasons for their RRM choice, but women did not 
report thinking about these when they made their initial decisions.   
Relief and Safety.  Women experienced concerns and uncertainty associated with their 
increased risk of breast cancer, particularly about the possibility of developing the disease in 
the future: “It’s just at the back of your mind.  It just sits there quietly but it’s there.  So 
hopefully it will disappear after that” (Participant 3).  Accompanying their election to 
undergo a RRM was a wish to reduce their risk of breast cancer, as well as to alleviate their 
fears of developing cancer, and they achieved a sense of relief by doing so: “Even if he 
[surgeon] said ‘we can’t really do anything other than take your boobs off’, that’s fine, I’ve 
more or less accepted, I’m not looking to have a perky pair, I’m not really bothered, you 
know, as long as I get rid of the worry and stress” (Participant 2).  Participants often 
emphasised that this was of more importance than cosmetic outcomes. 
Some participants perceived RRM as providing them safety from fear in the face of the 
recurrent uncertainty surrounding scans and tests, imprinted in their memory via their 
personal experience or via a vicarious awareness: “I’m thinking I can have yearly 
mammograms and have that thought in my mind all the time, or every time I go for my 
mammogram I’m going to be worrying - are they going to find something? - or I can have a 
mastectomy and I’m never going to have to worry about that again, am I?” (Participant 5). 
It appeared that for most of the participants interviewed, the notion of eradicating the 
tissue that can harbour the risk was strikingly convincing in comparison to the perceived 
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uncertainty of the effectiveness of other risk reducing options, which participants did not view 
as sufficient to reduce their risk nor to assuage their worry of developing breast cancer:  
“Well, from what I can tell my options are a healthy lifestyle or the surgery, and really 
the healthy lifestyle isn’t enough for me.  I would like to know that the tissue is gone, really” 
(Participant 3).   
Furthermore, some women, such as Participants 1 and 2, saw RRM as an option that 
would enable them to stop experiencing worry and to gain closure instead, which would have 
not been achieved by other risk reducing or early detection interventions: 
-! Q: “Why did you prefer this RRM option over the mammograms and yearly 
checks?” 
-! Participant 1: “Peace of mind, it’s just peace of mind all the time for me.  I just 
don’t want to live in fear.  I want to sort of put it to bed and let me move forward 
with my life” 
-! Q: “Yeah, so would you feel that the mammograms wouldn’t allow you to do 
that?” 
-! Participant 1: “No, they probably would, but it’s every year, do you know what I 
mean? It’s something you’re waiting for.  And I want to know now that I’ve done 
the best I can, and I can move forward”  
This was echoed by Participant 2: “It’s just that it’s quite final, once it’s done, it’s 
done.  And it means that you don’t have to keep coming back for more lumpectomies, or 
radiotherapy, all that’s gone and dusted”. 
In contrast with the sense of urgency that they conveyed when they first reached their 
decision to have RRM, after the option was discussed and agreed with their surgeons, several 
participants felt sufficiently safe from worry so as to request to postpone the surgical 
procedure in order to time it conveniently around important life events and commitments such 
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as weddings or holidays, or starting a new job role: “She [surgeon] would have done it within 
weeks but I had holidays, hen dos, two weddings, and her words were “well, when can you fit 
me in?”, so that’s what she said to me.” (Participant 4).  This postponement initiated by 
women did not affect their views of RRM or their certainty about their decision.   
‘This is my doing something’: Taking action, taking control. Women’s choice to 
undergo RRM appeared to stem from, or to reflect, their need to obtain a sense of control 
against the disempowerment they felt due to the uncertainty characterising many aspects of 
the disease and of its treatment: “The chemotherapy, the radiotherapy and, you know, the “oh 
my god, what if” and, like I say, the day I thought I was dying.  There’s no control over that.  
It comes in and it’s sitting looking at you and then you’ve got to go - hang on a minute, you 
know, I need to do something positive” (Participant 4). 
Women’s proactive motivations for electing to have a RRM were expressed in their 
perceptions of needing to do ‘all that they can’, a motivation that was often grounded in their 
strong wish to survive for their children and loved ones: “I can’t just sit back and do nothing 
because to sit back and do nothing is to give up and I won’t do that.  I want to do something 
because I want to be here for my children and that’s the main thing so I’m … I need to do 
something and this is my doing something” (Participant 7). 
Seemingly due to its attribute of being an active response to breast cancer risk, RRM 
was also viewed as a protection against regret in the future: “I had 4 tumours but they were at 
the back of my breast bone so I would never have felt them, and this is a fear factor of mine, I 
don’t want to put myself in that situation where I can’t feel them and it’s too late” (Participant 
1).  Other women, such as Participant 7, reflected the belief that a possible future diagnosis of 
breast cancer due to residual risk after RRM would be more bearable and preferable than the 
regret of not opting for the procedure that was available to her: “If I do it and I - I understand 
I could still get cancer - and I still get breast cancer bizarrely, but say I do, I would sit there 
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and think ‘but I did everything I could at that”’ … and that’s the way I view it.  To not do 
something when you can do something? No.  Do it.” 
After the decision - Reviewing 
After their RRM decision, women reviewing it by means of consulting other people’s views 
and by finding additional information about RRM.  
Post-decisional reviewing and processing. Following their choice, and prior to the 
surgical procedure taking place, women engaged in a post-decisional reviewing process of an 
iterative nature:  
-! Q: “So through that time, did your confidence in that decision waver, or did you 
change your mind at any point?” 
-! Participant 6: “It wavered very slightly, but only very slightly, and I think that was 
me being sure because I was so ‘yeah I’ll just have it done, I’m not bothered’, I 
didn’t want to look silly by then breaking down and having some sort of big 
breakdown after it and then somebody saying ‘well, you shouldn’t have been such 
a knob and said you can cope with it if you clearly can’t’ - so I was trying to get 
mentally prepared really, and the only time I thought ‘should I?’ is when I was just 
double-checking in my mind really.  I was just double-checking.” 
For women in this study, active reviewing of their decision also took place, for example, 
through conversations with other people including about loved ones’ views regarding RRM: 
“So it wasn’t a moment of doubt for me, it was just a moment of doubt from somebody else 
that made me think ‘well, am I doing the right thing?” (Participant 2).  One participant, whose 
husband worried about the risks of the procedure, described how the possibility of surgical 
complications concerned her but ultimately did not make her change her mind: “Well then the 
doubts come in and I did have a couple of sleepless nights when I thought - my God, you 
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know, I might die - and then all of a sudden I thought ‘I know I’m not going to die’, you know, 
and I don’t feel I’m going to die” (Participant 4). 
Participants sought additional information about the procedure, many primarily online, 
and described being selective about the information accessed: “It’s always interesting to see 
what people have been through and what they’re talking about and some of it you think ‘oh 
I’ll just ignore that one’ but a lot of them are quite interesting” (Participant 3).  None of the 
women used the information to question their choice, but it did serve them to ratify their 
decision and their confidence in RRM as the best option for them: 
-! Q: “What was the effect of researching that information on your decision?” 
-! Participant 3: Confirming really.   
-! Q: Confirming, yeah? 
-! Participant 3: Yeah.  I don’t think there was anything that made it less likely.  I 
don’t think anything put me off really.  Most of the stuff … well, most of the stuff 
that I found was quite positive.   
Only one contributor, Participant 7, described doubting her decision to have a RRM 
after having reached it with determination; this occurred in the context of her emotional 
reaction to a diagnosis of breast cancer and feelings of loss of control during its aftermath: 
“That’s when I broke down and I thought … I lost even more control.  I wasn’t me.  I realized 
I wasn’t me and I thought ‘I cannot make another decision again.  I don’t want to make 
another decision again’ and then my sister stepped back and she said ‘just go with what you 
did at the start.  Your own decision’”.  This period of hesitation about her choice to undergo 
RRM, precipitated by a perceived loss of control, was resolved by a return to a sense of 
certainty about her decision: nd I almost took a deep breath and thought ‘Yeah.  Yeah’.  I 
just needed her to tell me, someone to tell me that” (Participant 7). 
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Discussion 
This qualitative study explored women’s views of RRM and their decisions to undergo 
it.  Participants viewed breast cancer and its treatment as something they strongly wished to 
avoid, and made their decision to undergo RRM in an immediate and intuitive manner, 
regardless of how they had learned about this prophylactic option.  Participants reported that 
a RRM was an option that gave them a sense of safety and relief in the face of the worry and 
fear about breast cancer that they experienced.  Their decision was also a way to engage in a 
proactive action, which appeared to serve as protection from possible future regret. 
Participants did not report considering these reasons before the decision, however they 
reported experiencing fear, worry and loss of control. Subsequent to their decision, 
participants engaged in post-decisional processes that sustained their views of RRM being the 
preferred risk-reducing alternative for them.   
The results of this research are consistent with the findings reported by Brown et al.  
(2017) as well as with those described in the wider literature (Beesley et al., 2013; Fielden, 
Brown, Saini, Beesley, & Salmon, 2017; Simard et al., 2013).  The decision to undergo a 
RRM originated in response to the sense of menace or fear.  This fear was related to 
participants’ experiences of cancer, whether through personal diagnosis and treatment, or due 
to family and/or friends developing cancer.  As reported by Covelli et al. (2015), cancer risk 
perceptions and decision-making are shaped by the experience of affected family members, 
as opposed to statistical probabilities, and might be a motivating factor in prophylactic 
surgery (Singh et al., 2013).  Participants in this study communicated their experiential 
knowledge of the illness and its treatment, for example recounting salient stories of breast 
cancer recurrence in family members or other cancer affected patients, and expressed their 
determination to avoid both the disease and its treatment.  Fear of recurrence has been found 
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to be a principal concern among women with breast cancer (Fiszer, Dolbeault, Sultan, & 
Bredart, 2014). 
Participants formed their risk-management decision in an apparently immediate 
manner, for example voicing their preference to have a RRM when informed about their 
breast cancer diagnosis, or even prior to finding out the outcomes of their genetic mutation 
tests.  Furthermore, the stability of their choice was evident given that participants reported 
not changing their minds about their RRM decision.  This echoes van Dijk, Roosmalen, 
Oteen and Stalmeier’s (2008) findings that women had formed their risk-management 
preference before genetic test disclosure, and this preference did not change after a positive 
test result. 
Participants were not able to convey details of how their immediate decision was 
formed.  Despite not matching our initial expectations at the start of this research, this failure 
to expand upon the decision-making moment is informative.  It appears to indicate that, 
although women’s motivations for and views of the surgery are accessible to them, the 
manner in which they make their minds up might not be so, due to the immediate and 
instinctive attribute of the decision-making. 
The need to obtain a sense of control and to be proactive was often described in 
women’s accounts of ‘doing all that they could’ to prevent future breast cancer.  These 
imperative stances were associated with the disempowerment and vulnerability they 
experienced due to having breast cancer and undergoing treatment, as well as with their drive 
to survive for their loved ones.  Similar findings have been reported elsewhere (Haroun et al., 
2011).  Women’s anticipated emotions, such as anticipated feelings of regret in case of a 
negative outcome, are seemingly bound to their proactive stance and motivation to do all that 
they can in order to prevent future harm.  As argued by van Dijk et al. (2008), selecting the 
option of RRM due to perceiving it to be the safest option to avoid potential future self-blame 
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and regret is an understandable reason for choosing prophylactic surgery.  Nevertheless, 
evidence indicates that when making decisions associated with a heavy emotional burden 
people might act more inflexibly and might disregard trade-offs between costs and benefits 
(van Dijk et al., 2008). 
Affect and emotions play an influential role in decision-making (Zikmund-Fisher, 
Fagerlin, & Ubel, 2010), and recent research by Beesley et al. (2013) has found that 
psychological reasons such as the reduction of patients’ cancer worry influenced their 
decision to undergo CRRM.  Furthermore, Rendle, Halley, May and Frosch (2015) have 
found that an important decision-making factor for women opting to have a CRRM was 
avoidance of future breast cancer surveillance and of associated worry.  The findings of the 
present study reflect similar themes, with participants viewing RRM as an alternative that 
would enable them to stop experiencing cancer-related worry, and to gain a sense of relief 
from their concerns and of safety from their breast cancer risk. 
Participants’ post-decisional processing can be understood in light of Svenson’s 
Differentiation and Consolidation theory (Svenson, 1992).  The findings of this study suggest 
that the attractiveness of RRM might depend on the importance women place upon its salient 
attributes; namely, that it offers the possibility of maximizing risk reduction and perceived 
control whilst minimizing fear, worry, and future regret to a greater degree than the other 
risk-reduction alternatives available.  This might be the case even for participants for whom 
other risk-reduction alternatives such as chemoprevention were not suitable or those for 
whom surveillance would not guarantee early detection of breast cancer, as arguably an 
alternative to RRM would be to opt to decline it.  Following the decision to undergo a RRM, 
post-decisional processes enabled women to both to consolidate their decision and to 
minimise possible regret about making a wrong decision.  This refers to a process of 
justification reported elsewhere (Brown et al., 2017), which included accessing information 
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selectively and drawing on their family and friends to support their decisions, which appeared 
to be psychologically helpful for participants. 
Both patients’ appraisal of the attributes of RRM as the most convincing and suitable 
risk-reduction alternative and the subsequent consolidation processes appeared to be 
facilitated by heuristics.  An example of this might be the influence of availability and 
simulation heuristics upon individuals’ perceptions of their risk of breast cancer, since 
participants had either personal or familial experiences of this disease.  By means of the 
affect heuristic, it is also possible that participants’ conscious and unconscious emotional 
states might have influenced their information processing and thus decision-making.  For 
instance, it could be hypothesized that the positive feelings of relief and safety from worry 
associated with the prospect of reducing breast cancer risk, and the positive affect resulting 
from perceiving a gain of control by taking action, lead to participants’ view that RRM was 
the most convincing alternative and ‘the right thing to do’. 
Furthermore, this theoretical understanding might account for participants’ initial 
decision to have RRM remaining stable over time.  Differentiation and Consolidation theory 
postulates that the probability of a preliminary chosen alternative being the final choice is 
greater than the probability of it being changed for another option, even if its attributes are 
equally attractive (Svenson, 1992).  In this study none of the participants’ risk-reducing 
preferences oscillated between RRM and other options, indicating that their preliminary 
choice of undergoing a RRM remained the leading one throughout the differentiation and 
consolidation process.  Nevertheless, caution should be exercised when considering the 
above, due to the inherent selection bias of interviewing participants who had reached their 
decision to have a RRM and who did not intend to revisit it.  Further research is required to 
expand the findings of this study, and to include the views of women for whom the decision-
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making process was experienced differently, and of those who did not regard RRM as the 
most convincing alternative to manage their risk of breast cancer.   
 
Strengths and Limitations 
Participant recruitment was dependent upon the rate of patient referrals to the 
psychology service.  This precluded obtaining a larger sample of participants and therefore 
data saturation has not been reached, potentially limiting the generalisability of findings.  
Nevertheless, participant inclusion criteria for this study were purposefully broad in order to 
recruit a heterogeneous sample, representative of the population of women opting to have a 
RRM at the breast unit.  Thus, this study examined RRM views and decision-making 
processes in women with a wide-range of personal experiences, including personal or familial 
history of breast cancer, time since breast cancer diagnosis, genetic mutation status, and 
demographic information, some of whom were interviewed pre-operatively and others who 
had already undergone RRM.  However, the heterogeneity of the sample might affect the 
integration of the results into a unified picture as well as limit the generalisability of findings. 
The use of a qualitative methodology whereby a pragmatic approach to data analysis 
was adopted enabled researchers to continuously revise the ongoing investigation in light of 
the developing findings as new data emerged, allowing for the analysis and interpretation of 
participants’ experiences without a preemptive reduction of the data.  The use of face-to-face 
semi-structured interviews provided in-depth information about individuals’ views and 
beliefs (Ho, 2006); however, the use of this method of data collection might not adequately 
capture aspects of participants’ opinions nor of their decision-making process, such as those 
which are implicit, not accessible, or which participants are unwilling to share with the 
researcher.  For example, stressful experiences might affect memory processes and the ability 
to recall details of past events (Schwabe, Joëls, Roozendaal, Wolf, & Oitzl, 2012).   
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Furthermore, some participants indicated they had in the past considered, in hypothetical 
terms, what they would do regarding the option of RRM; these accounts might be an 
indication of earlier decisional processing that would merit further investigation. 
Key aspects of the research quality and validity have been carefully considered through 
this research, and are presented in depth in Appendix L. 
 
Clinical Implications and Future Research 
Advances in the understanding of women’s views of RRM and of the ways in which 
they make RRM choices are of immediate relevance to clinicians working with patients 
facing RRM. This study adds to a growing body of literature demonstrating that patients’ 
decisions about RRM are shaped by emotions; these decisions were reached in an immediate 
and decisive manner, and were followed by a process of post-decisional deliberation whereby 
the appraisal of the attributes and anticipated outcomes of RRM as the most convincing and 
suitable prophylactic option were sustained.  The role of emotions and of inferential rules 
such as heuristics in decision-making can have both positive and negative outcomes; indeed, 
De Vries, Fagerlin, Witteman and Scherer (2013) posit that emotion-based decision-making 
can be advantageous and lead to better decisions.  Thus, as has been argued by Brown et al. 
(2017), understanding the option to undergo a RRM as a means of reducing negative affect 
can be respected as an autonomous choice if risks and benefits have been taken into account 
by patients.   
Additionally, it is important for clinicians to understand and acknowledge the emotions 
and negative affect experienced by women at high risk of breast cancer, such as fear, worry 
or the motivation to do all they can to avoid future regret, and which are at the center of their 
decision-making process.  In this respect, it could be argued that some patients might benefit 
from psychological interventions aimed specifically at reducing these difficult emotions.  
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Furthermore, most women appeared to decide about RRM at an early stage of their illness or 
genetic counselling, before the risk-reducing option was discussed with them by health care 
professionals.  Therefore, it might be of benefit for comprehensive discussions about risk-
management preferences and about coping with breast cancer risk to be held between 
clinicians and patients at an early stage. 
Future research to expand upon the findings of this study can be considered.  
Participants were interviewed at one point in time after they were assessed as having reached 
their decision to undergo RRM.  Future investigations could adopt a longitudinal approach by 
interviewing women at different time points, including between the RRM decision being 
initially considered and after the RRM procedure has or has not taken place; this would be of 
particular relevance to investigate the experiences and views of patients who delay 
formalizing their decision to have an RRM, who subsequently change their minds about risk-
reduction strategies, or opt to not have a RRM. 
 
Conclusion 
Women at increased risk of breast cancer face complex decisions to manage this risk, 
with one of the options available being RRM.  The results from this study add to our 
understanding of the decision-making process regarding RRM, providing valuable insights 
into patients’ perspectives about their choice to undergo RRM and about the surgical 
procedure itself.  This research complements existing studies highlighting that patients might 
make RRM-related decisions guided by their emotions.  Additional research is needed to 
explore these findings in larger samples and among women who have had different 
experiences of RRM decision-making. 
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APPENDIX B  
LITERATURE SEARCHES AND SELECTION 
 
Table 1 
 Total combined search by database 
Database Results 
PsycINFO 
194 MEDLINE 
CINMAHL Plus 
Web of Science 294 
PubMed 15 
Scopus 270 
Total 773 
 
 
Table 2 
 Reasons for exclusion 
Reason Examples 
Sample Carer 
Child 
Current BC 
Male 
Not BC/Not increased risk of BC 
Professional sample 
Other 
Topic Not women’s experience 
Not specific to BC/RRM 
Other 
Methodology Single case study 
Type Review 
Poster 
Book 
Book critique 
Editorial/position paper 
Other 
Duplicate not previously identified 
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Table 3 
Exclusion from abstract 
Reason Number 
Sample 6 
Topic 55 
Methodology 0 
Type 31 
Duplicates not previously identified 0 
Total 92 
 
 
Table 4 
Exclusion from full text 
Reason Number 
Sample 6 
Topic 24 
Methodology 0 
Type 0 
Duplicates not previously identified 1 
Total 31 
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APPENDIX C 
QATSDD TABLE 
Criteria 
Hallowell 
(1998) 
Kwong 
& Chu 
(2012) 
Salant 
et al. 
(2006) 
Borreani 
et al. 
(2104) 
Claes et 
al. 
(2005) 
Haroun 
et al. 
(2011) 
Kram et 
al. 
(2006) 
Lerman 
et al. 
(2000) 
Litton 
et al. 
(2009) 
Lodder 
et al. 
(2002) 
Meiser 
et al. 
(2003) 
O’Neill 
et al. 
(2010) 
Ray et 
al. 
(2005) 
Explicit theoretical framework 3 3 2 1 2 1 2 1 3 3 3 2 3 
Statement of aims/objectives in main body of 
report 
3 3 3 3 3 3 3 3 3 2 3 3 3 
Clear description of research setting 3 3 2 3 3 3 3 3 3 3 3 3 3 
Evidence of sample size considered in terms of 
analysis 
0 0 0 0 3 0 0 0 0 2 0 0 0 
Representative sample or target group of a 
reasonable size 
2 2 3 3 2 3 2 3 2 3 3 3 2 
Description of procedure for data collection 3 3 2 1 3 3 3 3 3 1 3 3 3 
Rationale for choice of data collection tool(s) 2 2 3 0 1 1 1 3 1 0 2 2 2 
Detailed recruitment data 3 3 3 3 1 3 3 3 3 3 3 3 3 
Statistical assessment of reliability and validity 
of measurement tool(s) (Quantitative only) 
- - - 0 0 0 0 0 0 2 2 0 0 
Fit between research stated research question 
and method of data collection (Quantitative 
only) 
- - - 2 3 3 3 3 2 3 3 3 3 
Fit between stated research question and format 
and content of data collection tool 
(Qualitative only) 
3 3 3 - - - - - - - - - - 
Fit between research question and method of 
analysis 
3 3 3 3 3 3 3 3 3 2 3 3 3 
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Note. 0 = Not at all; 1 = Very slightly; 2 = Moderately; 3 = Complete.  
 
Summary 
The 16 items of the QATSDD were rated on a 4-point scale from “not at all” (0) to “complete” (3).  Comprehensive scoring guidance notes 
for all criteria can be found in Sirriyeh et al. (2012).  Percentage scores were calculated using the actual score and the maximum total score of 
42.  In order to categorise the quality ratings of the papers included in this review, studies scoring over 75% were considered to be of “high” 
quality, those between 50% and 75% were ranked as “good”, those between 25%–50% as “moderate”, and studies with a rating below 25% were 
considered to be of “poor” quality.  
 
An overview of the quality ratings as appraised by means of the QATSDD indicates that studies included in this review can be considered 
of overall good quality, with QATSDD ratings ranging from 78.57% to 52.38%, with an average score of 68.85%.  However, an examination of 
the individual criteria items of the QATSDD evidences some notable shortcomings in the methodological quality of the studies included in this 
Good justification for analytic method selected 2 2 2 0 2 1 2 2 1 3 2 1 2 
Assessment of reliability of analytic process 
(Qualitative only) 
1 1 1 - - - - - - - - - - 
Evidence of service user involvement in design 0 0 0 0 0 0 0 0 0 0 0 0 0 
Strengths and limitations critically discussed 3 3 3 3 3 3 3 3 3 3 3 3 3 
Total Score 31 31 30 22 29 27 28 30 27 30 33 28 30 
Percentage Score 73.8 73.8 71.42 52.38 69.04 64.28 66.66 71.42 64.28 71.42 78.57 66.66 71.42 
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review.  The most common areas of concern include the lack of justification of sample sizes, lack of references to reliability or validity of 
measures used, poor justifications for analysis methods, and complete absence of service user involvement in study designs.  
 
Reference 
Sirriyeh, R., Lawton, R., Gardner, P., & Armitage, G. (2012). Reviewing studies with diverse designs: the development and evaluation of a new 
tool. Journal of Evaluation in Clinical Practice, 18, 746–752. doi:10.1111/j.1365-2753.2011.01662.x.  
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APPENDIX D 
PARTICIPANT INFORMATION FORM 
 
 
Patient'and'surgeon'decision/making'in'risk/reducing'mastectomy:''
an'ethical'and'empirical'analysis'
'
'
'
'
'
'
'
'
'
'
You$are$being$ invited$ to$ take$part$ in$a$research$study.$$Before$you$decide$ to$
take$part$or$not,$it$is$important$for$you$to$understand$why$the$research$is$being$
done$and$what$it$will$involve.$$Please$take$time$to$read$the$following$information$
carefully$and$discuss$it$with$others$if$you$wish.$$Ask$us$if$there$is$anything$that$
is$not$clear,$or$if$you$would$like$more$information.$$Take$time$to$decide$whether$
or$not$you$wish$to$take$part.$
$
Thank$you$for$reading$this.$
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What'is'the'purpose'of'the'study?'
'
We$are$interested$to$learn$how$women$make$decisions$about$whether$to$have$a$risk@reducing$
mastectomy$or$not.$We$are$also$interested$in$how$clinical$staff$help$them$to$make$their$
decisions$and$how$they$see$their$role$in$the$decision$process.$We$hope$that$our$findings$will$
help$us$to$understand$how$clinicians$can$best$help$women$to$make$decisions$in$future.$$
$
Why'have'I'been'chosen?'
$
You$have$been$asked$to$take$part$in$the$study$because$we$understand$that$you$have$
considered$having$a$risk@reducing$mastectomy$at$the$Breast$Unit$of$the$Linda$McCartney$
Centre.$
$$
Do'I'have'to'take'part?'
'
You$do$not$have$to$take$part$in$this$study.$$It$is$up$to$you$to$decide$whether$or$not$to$take$part.$$
If$you$decide$to$take$part,$you$will$be$given$this$Information$Sheet$to$keep$and$will$be$asked$to$
sign$a$consent$form.$$If$you$decide$to$take$part$you$are$still$free$to$withdraw$at$any$time$and$
without$giving$a$reason.$$Whether$you$participate$or$not$will$not$affect$the$care$you$receive.$If$
you$were$to$participate$but$then$withdraw,$this$would$not$affect$the$care$you$receive$either.$
$
What'will'happen'to'me'if'I'take'part?'
'
If$you$choose$to$take$part,$you$will$be$given$a$copy$of$this$Information$Sheet$and$a$signed$
Consent$Form$to$keep.$
$
We$would$like$to$interview$you$about$how$you$have$thought$about$the$possibility$of$having$this$
operation$and$how$you$decided$about$it.$In$particular,$we$are$interested$in$how$you$thought$and$
felt$about$the$risk$of$cancer$and$risk@reducing$mastectomy$and$how$you$and$your$clinician$came$
to$decide$about$what$is$best$to$do.$You$can$choose$whether$you$would$prefer$to$be$interviewed$
at$the$Breast$Unit,$at$the$University$of$Liverpool$or$at$your$own$home.$$If$you$choose$to$be$
interviewed$at$the$Breast$Unit$or$the$University$of$Liverpool,$your$travel$expenses$will$be$paid.$$$
$
!$ Your$interview$will$be$audio@recorded$if$you$agree$to$this.$$The$length$of$the$interview$will$
vary,$depending$on$how$much$you$wish$to$talk$about.$$However,$the$interview$is$likely$to$
last$between$20$minutes$and$60$minutes.$$$
$
!$ The$audio@recordings$of$the$interview$will$be$typed$up$by$the$researcher.""All$information$
which$might$identify$you$will$be$removed$and$replaced$by$a$code$so$that$any$personal$
information$(such$as$names,$addresses,$doctors’$names$etc)$will$not$be$included$in$the$
research.$$$
$
!$ The$interview$will$focus$on$the$following$topics:$how$you$viewed$the$risk$of$breast$cancer$
(re)occurrence,$how$you$first$became$aware$of$the$possibility$of$having$a$risk@reducing$
mastectomy,$the$factors$that$contributed$to$your$preferences$to$have$the$risk@reducing$
mastectomy$or$not$and$how$you$and$the$clinical$staff$interacted$to$make$the$decision.$$
$
!$ With$your$permission,$we$would$also$like$to$interview$clinical$staff$who$have$been$involved$
in$this$decision.$$None$of$the$interviewees$will$be$told$what$any$other$interviewee$has$told$
us.$
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What'are'the'possible'disadvantages'of'taking'part?'
$
The$interview$may$involve$talking$about$information$that$was$or$is$upsetting$for$you.$However,$
you$do$not$have$to$talk$about$anything$you$do$not$wish$to.$$If$you$feel$that$you$need$help$with$
any$of$the$matters$that$we$have$discussed$one$of$the$research$team$will$be$happy$to$speak$to$
you$to$give$you$advice$on$further$sources$of$support.$$$
$
What'are'the'possible'benefits'of'taking'part?'
$
You$will$not$personally$benefit$from$taking$part$in$the$study.$$However,$any$information$that$you$
give$us$can$help$us$find$out$more$about$how$people$make$this$decision$and$about$the$roles$that$
clinical$staff$should$play.$$We$hope$that$our$findings$will$help$clinicians$to$be$more$effective$in$
helping$women$in$future.$
$
What'if'something'goes'wrong?'
'
If$you$wish$to$complain,$or$have$any$concerns$about$any$aspect$of$the$way$you$have$been$
approached$or$treated$during$the$course$of$this$study,$the$normal$National$Health$Service$
complaints$mechanisms$will$be$available$to$you.$You$can$complain$to:$
$
Customer$Relations$Team$
Royal$Liverpool$and$Broadgreen$University$Hospitals$NHS$Trust$
Prescot$Street$
Liverpool$
L7$8XP$
Tel:$0151$706$4903$
complaints@rlbuht.nhs.uk$
$
Liverpool$Women’s$Hospital$Patient$Quality$team$0151$702$4416$
$
Will'my'taking'part'in'this'study'be'kept'confidential?'
'
All$data$collected$for$this$study$will$be$kept$safely$and$securely$on$computer$and$on$transcribed$
paper$records.$Dr.$Stephen$Brown$will$be$the$custodian$of$all$study$data.$An$audio@recording$
will$be$made$of$the$interview$and$transcribed$onto$paper.$After$we$have$analysed$the$data$the$
audio@recording$will$be$destroyed.$All$information$about$you$will$be$confidential.$$Any$
information$which$identifies$you$(for$example,$your$name,$names$of$family,$friends,$and$doctors,$
addresses,$names$of$hospitals,$telephone$numbers,$date$of$birth,$and$employment)$will$be$
removed$from$transcriptions$and$replaced$by$a$code.""$$
$
What'will'happen'when'the'study'ends?'
'
After$all$identifying$details$have$been$removed$from$the$transcribed$records$of$consultations$
and$interviews,$these$will$be$analysed$by$the$study$team.$The$results$will$be$published$in$
reports$and$scientific$journals,$but$it$will$not$be$possible$to$identify$any$individuals$from$these$
reports.$$Any$quotation$used$in$the$writing$up$of$the$final$study$will$be$kept$anonymous.$$$$
$
With$your$permission,$transcripts$of$audio$recordings$of$interviews$and$consultations$will$be$
stored$at$the$University$of$Liverpool$for$10$years$after$the$end$of$this$study$for$possible$use$in$
future$studies.$If$you$consent$to$it,$a$printed$transcript$of$the$interview$will$be$offered$to$UK$Data$
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Archive$where$it$will$be$made$available$to$future$researchers.$All$information$that$might$enable$
you$to$be$recognised$will$be$removed$from$these$records$
$
What'will'happen'to'the'results'of'the'research'study?'
'
The$clinical$psychology$student$who$is$part$of$the$team$will$write$up$the$results$of$the$study$for$
the$Degree$of$Doctor$of$Clinical$Psychology.$This$thesis$will$be$kept$in$the$library$of$the$Division$
of$Clinical$Psychology,$University$of$Liverpool.$$A$copy$of$this$thesis$will$also$be$kept$in$the$
University’s$Library.$$After$the$interview,$you$can$ask$if$you$would$like$a$summary$of$these$
results,$which$will$then$be$available$after$October$2017.$$You$will$not$be$identified$in$these$
results.$
$
We$will$also$write$the$results$up$to$publish$them$in$academic$journals.$After$the$interview,$you$
can$also$ask$if$you$would$like$a$copy$of$these$publications.$You$will$not$be$identified$in$any$
publications.$
$
Who'is'organizing'and'funding'the'research?'
'
The$chief$investigator$is$Dr$Stephen$Brown,$a$senior$lecturer$at$Liverpool$University.$He$is$
collaborating$with$Professor$Peter$Salmon$and$Dr$Louise$Fairburn.$Ms$Emma$Shaw$Núñez$is$a$
student$in$Clinical$Psychology$who$is$conducting$the$research$as$part$of$her$qualification.$
$
The$Economic$and$Social$Research$Council$is$funding$the$research.$
$
$
Who'has'reviewed'the'study?'
'
The$study$has$been$reviewed$by:$
!$ The$Department$of$Psychological$Sciences$at$Liverpool$University$
!$ The$Economic$and$Social$Research$Committee$
!$ Liverpool$Local$Research$Ethics$Committee.$
'
Contact'information'
'
Stephen$Brown,$Chief$investigator$
Department$of$Psychological$Sciences$
University$of$Liverpool$
Liverpool$L693GB$
$
Tel:$0151$794$5526$
Email:$slbrown@liverpool.ac.uk$
$
For'independent'advice'please'contact:'
Patient$Advice$and$Liaison$Service'
Latham$Court'
Bridgemere$Close'
Liverpool'L7$0LS'
'
Tel:'0800$073$1106$
Email:$PALS@liverpoolpct.nhs.uk'
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APPENDIX E 
STUDY PARTICIPATION LETTER 
 
 
 
 
 
 
Dear!__________,!
!
I!am!contacting!you!as!in!the!past!year!you!have!attended!an!appointment!with!the!
Liverpool!Cancer!Psychology!Service!to!discuss!your!decision!to!have!risk!reducing!breast!
surgery.!You!will!have!met!with!Dr!Jan!Ablett,!Dr!Louise!Fairburn,!or!Dr!Lesley!Doyle,!Clinical!
Psychologists.!!!
!
In!collaboration!with!the!University!of!Liverpool!and!the!Royal!Liverpool!University!Hospital,!
we!are!currently!recruiting!for!a!research!study!entitled!‘Patient'and'Surgeon'Decision1
Making'in'Risk'Reducing'Surgery’!which!is!interested!in!learning!how!women!make!decisions!
about!whether!to!have!risk!reducing!mastectomy!or!not.!As!you!have!recently!made!this!
decision,!we!are!writing!to!ask!if!you!would!like!to!take!part!in!the!study.!!I!have!enclosed!an!
information!sheet!with!details!about!the!study.!
!
If!you!are!interested!in!participating,!or!would!like!to!discuss!anything!about!the!study,!then!
please!contact!the!psychology!service!on!0151!706!3126!by!the!end!of!March!2017!and!I!will!
be!happy!to!discuss!this!with!you.!If!you!would!like!to!participate,!the!interviews!would!last!
approximately!30!R!60!minutes!and!can!take!place!either!at!your!home!or!at!the!Linda!
McCartney!Centre,!whichever!you!prefer.!!
!
Yours!sincerely,!
Dr!Louise!Fairburn!
Macmillan!Principal!Clinical!Psychologist!
!
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APPENDIX F 
PARTICIPANT CONSENT FORM 
 
 '
'
$
$
$
Centre$Number:$
Participant$Identification$Number$for$this$study:$$
$
Patient$Consent$Form$$$
!
Title&of&Project:&
Patient&and&surgeon&decision4making&in&risk4reducing&mastectomy:&an&ethical&and&empirical&
analysis&
Name!of!researcher:! ______________!
! ! ! ! ! ! ! ! ! !!!!!!!!!!!!!!!!!!!Please!initial!box!
1.$ I!confirm!that!I!have!read!and!understand!the!information!sheet!dated!………..!
(version!…….)!for!the!above!study.!I!have!had!the!opportunity!of!consider!the!
information,!ask!questions!and!have!these!answered!satisfactorily.!
!
2.$ I!understand!that!my!participation!is!voluntary!and!that!I!am!free!to!withdraw!at!
any!time,!without!giving!any!reason,!without!my!medical!care!or!legal!rights!being!
affected.!
!
3.$ I!understand!that!audio!recordings!will!be!made!as!part!of!this!study,!and!that!brief!
quotations!from!some!interviews!or!consultations!may!be!included!in!study!reports.!
I!understand!nobody!will!be!able!to!identify!me!in!these!reports.!
!
4.$ I!agree!to!anonymous!records!of!my!interview!being!stored!at!the!University!of!
Liverpool!for!up!to!10!years!after!the!end!of!this!study.!!!
Yes! No!
5.$ I!agree!to!one!or!more!staff!who!have!participated!in!my!decision!being!
interviewed.!I!understand!that!no!details!of!what!I!have!said!will!be!made!known!to!
them.!!
Yes! No!
6.$ I!agree!to!an!anonymous!transcript!of!my!interview!being!held!by!the!UK!Data!
Archive!and!this!being!available!to!other!researchers!registered!with!UK!Data!
Archive.!
Yes! No!
7.$ I!would!like!to!receive!a!summary!of!the!findings!at!the!end!of!the!study.!! Yes! No!
8.$ I!agree!to!take!part!in!the!above!study.!! !
!
!
! ! ! !
Name!of!participant!
!
!
!
! Date! ! Signature!
Name!of!researcher! ! !!!!!!!!!!!!Date! ! ! !!!!!!!!!Signature!
!
RRM PERCEPTIONS AND DECISION-MAKING AMONG WOMEN AT HIGH RISK OF BC 
! 96 
APPENDIX G 
ADDITIONAL STUDY DETAILS 
Wider Study Information 
This research was part of a wider study, ‘Patient and surgeon decision-making in risk-
reducing mastectomy: An ethical and empirical analysis’, developed and conducted by 
researchers at the University of Liverpool and an NHS breast unit. The aims of this wider 
study are as follows: 
1.$ To identify the outcomes that women consider when they form CRRM and BRRM 
preferences, whether and how they consider the concept of risk and how risk and 
distress affect their decision processes.   
2.$ To understand how surgeons’ perceptions of patients’ best interests are formed, how 
the surgeons introduce and respond to requests for RRM, the role of distress in 
justifying or avoiding RRM, and how surgeons respond to requests that they may feel 
are ill-made.   
3.$ To better understand how patients’ and surgeons’ joint decisions are negotiated, 
including any modifications that they may make to previous positions and the reasons 
for these.   
4.$ To place these findings in relation to current thinking in medical decision-making and 
ethics with a view to determining better modes of practice in making RRM decisions.   
Initial findings from this wider study suggested that women’s decisions to undergo 
RRM was driven by fear of breast cancer and the belief that they should do all they can to 
reduce risk, not by a utility-based comparison of risks of cancer and side effects of RRM.  
Women reported engaging in deliberative decision-making strategies, but these were seen as 
justifications for a decision that had already been taken.  These results have been published 
elsewhere (Brown et al., 2017).  Due to these interesting initial findings, there was an 
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opportunity for further investigation to be carried out with regards to patients’ views of RRM 
and their decision-making, in line with the wider study aims and as a means of developing 
further the emerging outcomes.  The researcher (ESN) was involved in planning the focus of 
the research here presented, in order for it to complement the ongoing wider study whilst 
being sufficiently different from previous research, so as to add novel evidence to the 
literature.  Additionally, ESN led the reviewing and refining of the interview guide, as well as 
all aspects of data collection and analysis for this study.  Data analysis was jointly conducted 
with the study supervisors, who were researchers in the wider project.  The data and findings 
of this study will form part of the aforementioned wider study, which continues to be 
ongoing.   
Ethics and Procedure 
The wider study received ethical approval by the local NHS Research Ethics committee 
(13/NW/0421) and sponsorship from the University of Liverpool (UoL000957).  The trainee 
clinical psychologist also received approval to collaborate in the study, and the NHS Trust 
granted the trainee a letter of access to conduct research within their organisation. 
Patients were first informed about the study by clinical psychologists working at the 
breast unit, either in person or via written correspondence (see Appendix E).  The purpose of 
this recruitment strategy was two-fold: on one hand, to ensure only the inclusion of patients 
who had indicated they had reached a firm decision regarding RRM and did not plan to 
revisit this decision and, on the other hand, to ensure that patients were able to provide 
informed consent to participate. 
Clinical psychologists aiding with recruitment were asked to not approach women who 
had been interviewed in the initial phase of the wider study, nor those who had previously 
declined to participate.  Patients who indicated to the Clinical Psychologists an interest in 
participating in the study were provided a Participant Information Sheet (Appendix D) and 
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were requested permission for the researcher (ESN) to contact them.  The researcher 
established contact with the potentially interested patients by telephone in order to explain the 
study in further detail and to answer any questions raised by patients.  To ensure adequate 
time to consider participation, telephone contact was made again after several days.  All 
patients contacted this way indicated their interest in participating in the study, and 
interviews were arranged at a convenient time and location. Six participants were interviewed 
in a private room in a hospital setting and one was interviewed in their own home.  To ensure 
the safety of the researcher, the University of Liverpool’s lone working policy was adhered 
to.  Prior to obtaining written consent and to the interviews commencing, the study 
information was verbally reiterated to patients in person in accessible language, and there 
was an opportunity to discuss any queries.  The researcher reiterated to patients that their 
participation was completely voluntary and would not impact on their care. 
Patients who consented to participate were informed that all information provided 
would be anonymous unless there were any concerns for their safety or that of others, as 
stipulated in the Dealing with Distress Protocol (Appendix K).  During the conduct of this 
study, there were no cases that required breaches of confidentiality.  Participants were also 
informed of their right to withdraw or remove their data without negative consequences.  No 
participants in this study opted to do so.  All participants were offered £6 to cover transport 
and/or parking costs.  Four participants received this amount, and three participants declined 
it. 
The Data Protection Protocol (Appendix J) was followed for the management of data 
throughout the study.  Data were recorded using a digital audio recording device and was 
subsequently transferred to a secure computer file store at the University of Liverpool at the 
earliest opportunity, following which it was removed from the audio recorder.  The 
researcher transcribed the initial two interviews, and a transcriber approved by the University 
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of Liverpool transcribed subsequent interviews.  The transcriber was provided a template and 
specific guidance (see Appendix M) to ensure the confidentiality and anonymity of 
participants were protected.  Following consistency checks and the removal of any potential 
identifying information, audio recordings were deleted.  Anonymised interview transcripts 
were shared via email with the research supervisors for analysis.  Anonymised demographic 
information was linked to the interviews by a participant identification number.  Participants 
were informed that anonymised interview transcripts would be stored at the University of 
Liverpool for up to ten years, after which it would be destroyed.  Signed consent forms were 
kept for the duration of the study and stored in a locked cabinet at the University of 
Liverpool.  The data custodian (principal investigator) was responsible for ensuring data and 
identifiable information will be destroyed after the adequate time period. 
 
Reference 
Brown, S. L., Whiting, D., Fielden, H. G., Saini, P., Beesley, H., Holcombe, C., . . . Salmon, 
P. (2017). Qualitative analysis of how patients decide that they want risk-reducing 
mastectomy, and the implications for surgeons in responding to emotionally-motivated 
patient requests. PloS One, 12(5), e0178392. doi:10.1371/journal.pone.0178392 
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APPENDIX H 
PARTICIPANT DEMOGRAPHIC FORM 
 
Participant ID: ____________________  
 
Age (please tick):  
  
16-20" 21-25" 26-30"  
31-35" 36-40" 41-45"  
46-50" 51-55" 56-60"  
61-65" 66-70" 70+"  
Education (please tick highest 
qualification):  
GCSEs or equivalent"  
NVQ " 
A-Levels or equivalent "  
Bachelor’s degree"  
Post-graduate degree"  
 
Employment status (please tick):  
 
Unemployed " Long-term sick "  
Part-time " Full-time "  Retired  "  
 
Previous breast cancer (please tick):  
 
Yes " No"  
Time since diagnosis of breast cancer 
(if applicable):  
 
___________________________ 
Time since end of treatment for breast 
cancer (if applicable):  ___________________________ 
BRCA 1/2 status  Positive " Negative " Unknown "  
Previous other cancer (please tick):  Yes " No"  
Family history of breast cancer  
(please tick):  Yes " No"  
Family history of other cancer  
(please tick):  Yes " No"  
Risk-reducing surgery (please tick):  Contralateral " Bilateral "  
!
'
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APPENDIX I 
INTERVIEW GUIDE WITH REFINEMENTS 
 
Please note: Italics denote refinements. 
Interviews will be at a time convenient for the patient.  The interview will be conducted 
at the hospital, at the patient’s home or by telephone as the participant prefers.  For 
consistency, and to ensure that the research questions are addressed, a semi-structured 
approach will be used, with participants prompted to address specific topics in each 
interview.  
Closed questions will be avoided as much as possible as these constrain the information 
gained from the participants.  For this reason, interruptions from the interviewer will be kept 
to a minimum with interviewer dialogue limited to reflecting, prompting and summarising, 
with open or closed questions and probing where necessary.  To avoid generalised responses, 
participants will be encouraged to speak about their specific experiences as much as possible.  
Before the interview commences it is essential to ensure that the patient has read the 
information sheet, and that they have made a decision and do not plan to revisit it.  
Questions and prompts below are resources on which the interviewer will draw and only 
relevant questions should be asked.  Questions should not be imposed to disrupt 
conversational style.  
1.$ Introduction. 
2.$ Reassurance of confidentiality (including reassurance that their doctors and nurses 
and other clinicians will not be told what the participant has said and that their 
treatment will not be affected by what they say, unless they say something that 
indicates risk). 
3.$ Clarification of research aims. 
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4.$ Elicit and answer questions about the interview process and the Patient Information 
Sheet. 
5.$ The interview questions will be guided by the structure below.  The questions are 
illustrative and the format and sequencing will be guided by the patient’s responses.  
 
1.'  Finding out about RRM: 
R$ When did you first hear about RRM?  
R$ Ask whether before diagnosis/illness. 
R$ How did you first hear about RRM? 
R$ Explore with further questioning if aware of RRM due to family or friends, 
media, own research, professionals, etc. 
R$ What did you draw from this information? How did you use it? 
R$ If it was before experience of cancer: At that time, what did you think about RRM? 
What was your reaction? 
2.' RRM as an option: 
R$ When did you first consider RRM as an option for you? / Did you ever consider RRM 
as an option for you? 
R$ Who thought about the option of RRM first?  
R$ Enquire about specific times and people, e.g. where were you? 
R$ What was on your mind at the time? / what did you think? 
R$ What did it change, when the RRM decision was made? 
R$ Enquire further if their decision led to a sense of relief. 
R$ What do you mean by ‘taking back control’? 
3.   RRM decision-making: 
R$ Tell me about how you came to the decision [prompting any specific topics] 
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R$ How did you make that decision? 
R$ What did making the decision/the decision itself do? 
R$ If worry/peace of mind is mentioned, ask what would the worry be about? 
R$ What factors were going on in your life at the time that influenced whether you 
wanted/not wanted to have RRM?  
R$ Who did you talk to about it? What did you tell them about it? 
R$ Where other preventative options discussed with you? Did you consider other 
preventative options?  
R$ Enquire about specific times and people, e.g. where were you? 
R$ What did you think at that time? 
R$ If they did consider other preventative options but changed their mind: Could you 
describe what/who made you change your mind? Any reasons if decided against 
them? 
R$ After your decision, were there any moments of doubt? e.g. anything you 
learned/someone said that made you question your decision? Tell me about it. 
4. Views of RRM & other preventative methods: 
R$ Have you encountered anything in your life that may have similarities with your 
decision about RRM? 
R$ How have you explained what RRM is to other people/to people who were not 
familiar with it?  
R$ What was it about RRM specifically that made you decide to have it/not to have it? 
R$ Is there anything unique or different about RRM compared to other options? 
R$ Has your view on that changed over time? 
R$ What was it about [other preventative option] specifically that made you decide to 
have RRM/not to have RRM? 
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R$ Depending on response: What was it about other methods that were not as 
suitable or as convincing for you?  
R$ Did you seek the opinion of other people about RRM? Why? 
R$ If sought other people’s views: Whose and what did they say? How did 
this influence your opinion of RRM? 
R$ If they say it was ‘the obvious thing to do’/’a no-brainer’: Why did you consider 
RRM as ‘the obvious thing to do’/’a no-brainer’? What lead you to consider RRM as 
‘the obvious thing to do’/’a no-brainer’? 
R$ Imagine you had not been able to have RM, what would this mean for you? 
R$ Has your view/opinion of RRM changed at any point, either before or after you made 
your decision? If so, what person/event influenced that? 
R$ Enquire about fear of future regret or worry of future regret influencing decision-
making or RRM perception. 
R$ Ask about risk perception, e.g. what risk is left to them after the operation? 
5.  Final questions:  
R$ What do you think was the biggest influence in reaching your decision? Why? 
R$ How easy or difficult was it to make the decision? Why? 
6.  Ending: 
R$ Does the participant have any questions or any concerns about anything that has been 
talked about? 
R$ Thank participant for taking part.  
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APPENDIX J 
DATA PROTECTION PROTOCOL 
 
Demographic information will be pseudo-anonymised (to link with interview 
transcript) and all potentially identifying information will be removed/ replaced with a code.  
Information will be stored electronically at The University of Liverpool on a secure password 
protected computer system.  Research team members only will have access to the transcripts 
during analysis.  Following transfer to the computer, raw data (paper files e.g. demographic 
information) will be stored in the D.Clin.Psychol. office.   
Interviews will be recorded on a digital dictaphone; audio data will be transferred on to 
a university password protected computer as soon as possible.  Following transfer to 
computer, audio data stored on the dictaphone will be deleted.   
A university approved transcription service will be responsible for most transcriptions.  
Emma Shaw Núñez (Trainee Clinical Psychologist) will be responsible for ensuring that the 
transcription service employed during the investigation has deleted all electronic copies of 
the data from their computer hard drives/portable disk drives etc. sent by Emma Shaw Núñez 
(Trainee Clinical Psychologist).  When data is part of the wider study and sent for 
transcription by a member of the wider research team, responsibility for data deletion will fall 
to the data custodian, Dr Steve Brown (Chief Investigator/ supervisor).   
Transcriptions will be pseudo-anonymised with respect to all names of people and 
places and other potentially identifying information.  Transcripts will be stored electronically 
at The University of Liverpool on a secure password protected computer system.  Research 
team members only will have access to the transcripts during analysis.   
Emma Shaw Núñez (Trainee Clinical Psychologist) will retain an electronic copy of all 
transcribed files for her own records until the point of the viva voce examination.  Up-to-date 
copies of all electronic files (relevant to the thesis) will be stored on researcher’s allocated 
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workspace on the University computer network.  Transcribed files will not be kept on any 
home PC.   
Following the viva voce examination, Emma Shaw Núñez (Trainee Clinical 
Psychologist) will submit hard data to the D.Clin.Psychol. office for secure destruction by the 
University Records Management Service.   
All the electronic data relating to the thesis will be archived on a CD.  The CD 
containing the electronic data and any remaining copies of the raw hard data, such as 
participant consent forms, will be given to the data custodian, Dr Steve Brown (Chief 
Investigator/ supervisor), who will be responsible for data storage.  Transcripts will be 
archived with the Economic and Social Data Service for access by other researchers (data 
sharing procedures are explained in ESDS (2012) Managing and Sharing Data (p.23) 
http://www.data-archive.ac.uk/media/2894/managingsharing.pdf).  This will be explained to 
patients and they will be asked to consent to it.   
It is the responsibility of the data custodian to ensure that all hard and electronic copies 
of any data files that relate to the major research project at the end of the data retention period 
have been securely destroyed.   
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APPENDIX K 
DEALING WITH DISTRESS PROTOCOL 
 
Within the information sheet, participants are informed that they do not have to take 
part in the study and are free to withdraw at any point without negative consequences for the 
participant.  The researcher will reiterate this information as regularly as is felt necessary.  
If a participant becomes distressed during the course of the interview (visually appears 
distressed or informs the researcher that this is the case), the interview will be paused and the 
participant will be asked if she wishes to continue, or if she wishes to interrupt or stop the 
interview and/or if she wishes to discuss her concerns with the researcher.  
If the researcher is concerned about the degree of distress, the participant should be 
encouraged to contact their GP or mental health provider or, with the participant’s consent, 
the researcher will ask a member of the research team to do so.  The researcher will also 
provide the participant with contact details and information about MacMillan Cancer support 
(0808 808 00 00 Mon-Fri 9am – 8pm, or online community), Breast Cancer Care (0808 800 
6000 Mon-Fri 9amd-5pm, Weds 9am-7pm, Sat 9am-1pm) and/or Samaritans (0151 708 8888 
Liverpool and Merseyside; or 116 123).  With consent, the researcher will inform the Clinical 
Psychologist from the Liverpool Cancer Psychology Service of the distress experienced.  
If the researcher is concerned that the participant is at risk of harm, or that someone 
else is at risk, she will seek her consent to refer these concerns to an appropriate clinician. 
However, the duty of care would mean that, even if consent were not provided, the researcher 
would need to make this referral as appropriate.  
If the participant feels able and the researcher agrees, the interview will be resumed. 
With consent, the participant will be contacted the following day.  The participant will be 
encouraged to contact the research team if she experiences increased distress in the hours/ 
days following the interview.  Contact numbers for the research team are supplied on the 
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participant information sheet.  
If a participant becomes distressed the researcher will record the action taken.  
If the participant feels unhappy with the interview process and wishes to complain, the 
participant will be directed to the contact details for the Customer Relations Team on the 
participant information sheet.  
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APPENDIX L 
LAY SUMMARY OF RESULTS FOR PARTICIPANTS 
 
 
 
 
 
 
Dear!__________,!
!
I!would!like!to!thank!you!again!for!taking!part!in!the!research!project!!
Patient&and&surgeon&decision4making&in&risk4reducing&mastectomy:&&
an&ethical&and&empirical&analysis&
!
As!part!of!this!project,!and!of!my!Doctorate!in!Clinical!Psychology!research,!we!carried!out!
interviews!in!2016!and!2017!with!women!who!had!opted!to!have!a!riskRreducing!mastectomy!
(RRM).! I! am! writing! to! provide! you! with! a! summary! of! the! results.! I! hope! you! find! this!
summary!and!the!results!of!interest:!
!
Why&did&we&do&this&study?&
-$ Breast!cancer!is!the!most!common!cancer!in!the!UK.!Cancer!Research!UK!estimate!that!1!
in!8!women!are!diagnosed!with!breast!cancer!in!their!lifetime.!
-$ There!is!research!suggesting!that!many!factors!can!play!a!role!in!how!women!decide!to!
have!a!RRM,!including!psychological!factors.!For!example,!decisions!can!be!influenced!by!
perceptions!of!risk!of!developing!breast!cancer!or!by!cancerRrelated!worry.!
-$ During!the!first!part!of!this!study!(carried!out!in!2013)!we!found!that!patients!decided!to!
choose!RRM!because!they!felt!vulnerable!to!breast!cancer,!and!that!many!patients!made!
immediate!decisions!about!wanting!to!have!a!RRM.!This!was!because!they!wanted!to!do!
all!they!could!to!eliminate!risk.!
We' aimed' to' find' out' more' information' about' what' women' thought' about' RRM' as' a'
convincing'option,'and'about'how'they'reached'their'decision'to'have'a'RRM.'
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How&did&we&do&this&study?&
-$ Each!participant!was!interviewed!about!their!own!experiences!of!deciding!to!have!a!RRM.!
All!participants!had!in!common!that!they!were!over!18!years!old,!they!could!speak!English!
fluently,!they!had!reached!a!decision!to!have!a!RRM,!and!they!had!attended!a!consultation!
with!a!clinical!psychologist!about!this.!!
-$ To!date!we!have!interviewed!7!participants;!with!the!data!that!we!have!collected!we!have!
found!some!helpful!results.!We!will!continue!to!interview!more!women!if!possible,!which!
will!help!us!to!confirm!the!results!we!have!found.!!!
!
What&were&the&results&of&the&study?&
In!total,!2!participants!had!already!had!a!RRM!and!5!were!waiting!for!it.!Three!of!the!
participants!had!a!known!genetic!mutation!(BRCA1/2!or!CHEK2).!Five!had!had!breast!cancer!
and!two!had!not.!All!participants!had!either!close!family!members!or!friends!who!had!suffered!
cancer.!
!
Analysing!the!content!of!the!interviews,!we!found!that:!
-$ Participants! found! out! about! RRM! in! many! different! ways,! including! through! family!
members,!through!media,!or!through!other!patients.!Most!participants!had!made!their!
decision!that!they!wanted!a!RRM!before!the!option!had!been!suggested!by!clinical!staff.!
-$ Although! participants! had! different! personal! and! family! experiences! of! cancer,! and!
although! they! had! first! learned! about! RRM! in! different! ways,! how! they! made! their!
decision!to!have!a!RRM!was!similar!because!they!decided!in!an!immediate!and!determined!
way.!!
-$ Participants! described! cancer! and! the! treatment! of! the! illness! (e.g.! chemotherapy,!
radiotherapy)! as! something! they! understandably! wanted! to! avoid.! Wanting! to! avoid!
future!breast!cancer!and!future!treatment!was!a!strong!reason!to!opt!for!RRM.!!
-$ RRM!was!an!option!that!gave!participants!a!sense!of!relief!and!of!safety!from!fear,!because!
it! reduced! their! worry! of! developing! cancer! and! it! freed! them! from! the! uncertainty!
surrounding!scans!and!tests.!
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-$ RRM! was! an! option! that! enabled! participants! to! take! control,! because! they! had! felt!
disempowered! by! the! illness! and! treatment.! It! was! also! an! option! that! protected!
participants!from!regretting!not!having!done!all!they!could!in!the!future.!This!was!related!
to!wanting!to!survive!to!be!there!for!their!loved!ones.!
-$ After!making!their!minds!up!to!have!a!RRM,!women!had!to!wait!a!period!of!time!for!it!to!
take!place!(as!part!of!the!usual!clinical!pathway),!and!this!involved!discussing!the!decision!
with! clinical! staff! and! with! other! people! in! their! lives.! During! this! time,! participants!
reviewed!their!decision,!but!did!not!change!their!minds!that!RRM!was!the!best!option!for!
them.!
!
Why&is&this&study&important?&
It! is! important! that!health! care! staff!working!with!women!who!are!at! risk!of!breast!
cancer! and! opt! to! have! a! RRM!understand! how! and!why! these! decisions! are!made.! This!
includes! understanding!what! women! think! about! RRM! and!why! they! perceive! it! to! be! a!
convincing! option.! It! also! encompasses! understanding! that! the! RRM! decision! is! often!
immediate,!and!that!this!might!be!related!to!psychological!factors!such!as!emotions.!
!
This!is!a!small!study!still!in!progress,!but!nevertheless!it!adds!new!information!to!the!
growing!body!of!evidence!in!this!field!of!research.!!!
!
We&would&once&again&like&to&express&our&gratitude&for&giving&your&time&to&take&part&&
in&this&research&–&thank&you!&
!
Contact&us:&
If!you!would!like!any!further!information!about!this!study,!please!feel!free!to!contact!us.!!
-$ Before! 30th! September! 2017:! please! contact! Emma! Shaw! Núñez! (Trainee! Clinical!
Psychologist,! D.Clin.Psychol.! Programme,! The!University! of! Liverpool)! via! email! on!
emmasn@liverpool.ac.uk!
-$ After! 30th! September! 2017:! please! contact! Dr! Steve! Brown! (Senior! Lecturer,! The!
University!of!Liverpool)!via!email!on!slbrown@liverpool.ac.uk!!
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APPENDIX M 
INSTRUCTIONS FOR TRANSCRIBER 
 
TRANSCRIPTION&GUIDANCE&
!
Thank!you!for!doing!interview!transcriptions!for!this!research!project.!The!key!points!below!
are!guidelines!to!help!you!whilst!doing!this.!It!will!be!important!to!follow!these!in!order!to!
comply!with!ethical!standards.!If!you!have!any!queries,!please!do!not!hesitate!to!contact!me!
on!emmasn@liv.ac.uk!
!
#$ The!interviews!in!this!research!are!with!women!who!have!reached!a!decision!about!
whether!to!have!a!risk!reducing!mastectomy!or!not.!On!occasions!they!might!discuss!
topics! which!might! be! upsetting! to! hear,! including! the! consequences! of! suffering!
cancer! or! the! reasons! why! they! made! their! decision.! If! you! do! find! an! interview!
upsetting,!please!remember!that!you!can!stop!transcribing!if!you!wish!to!do!so.!You!
can!also!contact!me!via!the!email!address!above!if!you!want!to!discuss!this!any!further.!
!
#$ It! is! likely!that!you!might!encounter!some!terms!or!words!which!are!specific!to!the!
area!of!research!of!this!project.!Some!of!them!might!include:!
!
o$ RRM'or'risk'reducing'mastectomy:!Surgery!to!remove!the!tissue!of!one!or!both!
breasts.!
o$ BRCA1'and'BRCA2'[pronounced'“bracka”]:!Gene!mutation!that!might!increase!
the!risk!of!developing!breast!cancer.!
o$ CHEK2:! Gene!mutation! that!might! increase! the! risk! of! developing! different!
types!of!cancer.!
o$ Tamoxifen:!a!drug!used!to!treat!breast!cancer.!
o$ Oophorectomy:!the!surgical!removal!of!the!ovaries.!
o$ Lumpectomy:! the!surgical! removal!of!a!suspected!cancerous!tumour! from!a!
woman’s!breast.!
!
#$ Please!use!the!transcription!template!provided.!It!is!a!word!document!formatted!in!
advance!for!your!convenience!and!to!ensure!that!all!transcriptions!follow!the!same!
standard!format.!A!copy!of!it!will!be!saved!in!the!encrypted!memory!stick.!
!
#$ In!order!to!protect!participants’!confidentiality,!it!is!important!to!not!transcribe!any!
personal!identifiable!information,!including!names,!addresses,!locations,!very!unique!
professions,!etc.!When!transcribing!the!interview,!please!substitute!these!terms!with!
generic!ones.!For!example:!
!
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o$ John!=![name]!
o$ Dr!Doe!=![doctor]!or![staff]!
o$ London!=![city]!
o$ Template!University!Teaching!Hospital!=![hospital]!
!
#$ If! in! doubt,! please! do! not! transcribe! the! information.! Instead,! substitute! it!with! a!
generic! term! and! highlight! it! and! noting! the! minutes! of! the! audio! file,! such! as!
[profession]!0:34:11.!This!will!allow!the!researchers!to!locate!it!in!the!text!in!order!to!
decide!whether!to!include!it!in!the!transcript!or!not.!!
!
#$ Similarly,!if!there!is!a!section!of!the!audio!recording!which!is!unintelligible!or!inaudible,!
please!mark!this!in!the!text!by!highlighting!it!and!noting!the!minutes!of!the!audio!file,!
for!example![inaudible?]!00:34:11!
!
#$ Please!do!not!save!the!audio!recordings!or!transcripts!in!any!other!computer,!drive!or!
external!memory!device.!They!should!only!be!saved!on!the!encrypted!memory!stick!
provided.!
!
#$ Please!keep!the!password!for!the!encryption!software!in!a!safe!place,!do!not!share!it!
with!anybody!else!and!do!not!store!it!with!the!memory!stick.!
!
#$ Once!you!have!transcribed!an!interview,!please!let!me!know!the!number!of!hours!that!
it! has! taken! you! to! do! this!work.! I!will! confirm! that! the! transcript! is! saved! in! the!
encrypted! memory! stick! and! then! email! the! finance! department! with! a! payment!
memo!for!your!work.!I!will!aim!to!do!so!within!the!same!day.!
!!
Thank!you!again!for!your!help!transcribing!interviews!for!this!research!project.!
!
Emma!Shaw!Núñez!
Trainee!Clinical!Psychologist!
University!of!Liverpool!
Department!of!Clinical!Psychology!
Whelan!Building,!Brownlow!Hill!
Liverpool!
L69!3GB!
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APPENDIX N 
METHODOLOGY 
The aims of the study required a primarily inductive approach, for to date there have 
been scarce theoretical studies examining the influence of affect and emotions on how 
patients view RRM and decide about its uptake; thus, a qualitative method was followed.  
The qualitative approach to analysis and interpretation is explained in the main body of the 
thesis, supplemented with information below.  This method of qualitative analysis is based on 
previous research conducted by the study investigators (Wright, Holcombe & Salmon, 2004; 
Salmon, Mendick & Young, 2011; Brown et al., 2017). 
 
Epistemology and Data Analysis 
Qualitative pluralism proposes the combination of multiple epistemological and/or 
methodological frameworks for the understanding of experiences, as required by the data and 
emerging analysis (Frost, 2011).  The use of pluralist qualitative methodologies is increasing, 
with guidance about how to conduct pluralist qualitative research ensuring rigour and validity 
increasingly available (e.g. Frost, 2011).  A pragmatic, constant comparative approach was 
followed throughout the analysis, whereby analytic categories were developed both 
descriptively, in relation to the content of patients’ interviews, and theoretically, addressing 
the meaning and function of speech in context.   
The study aimed to understand patients’ views of RRM and gain further insights about 
their decision-making.  Data analysis began descriptively, an approach that can be situated 
within a largely positivist position, initially drawing from a thematic analysis approach in 
order to identify recurrent subjects and foci in participants’ accounts.  An example of this was 
the identification of the expressions pertaining to ‘losing and taking control’, ‘taking action’, 
and ‘doing all they can’, which led to this recurrent feature to be investigated further in 
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subsequent interviews and informed the finding that RRM was seen as a proactive choice in 
the face of the loss of control experienced due to breast cancer and its treatment. 
The analysis became more interpretative as the themes or analytic categories were 
developed, which enabled the data to be considered in the context of the interview as a 
whole, in the context of previous interviews, within the wider study, and within broader 
social contexts.  Drawing from interpretative analytic approaches, adopting a social 
constructionist position, enabled the data analysis to progress further.  The content, meaning 
and function of participants’ accounts were, therefore, carefully considered and guided the 
analysis, as did the awareness of the limitations of interviews for data collection.  It was 
recognised that interviews carry the danger that past events, views and processes might be 
misremembered or reconstructed for congruence with current circumstances and 
perspectives.  Furthermore, the potential tendency of interviews about emotive topics to elicit 
justifications rather than explanations for behaviour was acknowledged.  In this respect, 
interviews were not regarded as necessarily providing direct access to participants’ 
experiences and intentions, and the interpretative approach shaped the analysis.  An example 
of the above was the hypothesis that RRM, in that it removes most of the tissue which can 
harbour the risk of breast cancer, was viewed as a more reassuring procedure than other risk-
reducing options, e.g.  healthy lifestyle changes, the risk-reducing outcomes of which were 
conceptually not as straightforward. 
Whilst the analysis was developing and new interviews were carried out, previous 
interviews were regularly revisited, ‘cycling’ between the emerging findings and the data to 
test, refine and elaborate the framework of findings; this was achieved by examining 
commonalities across the data whilst attending to heterogeneity and divergence too.  This 
approach enabled the identification of pivotal cases or outliers, which were highlighted and 
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discussed in the analysis; a pertinent example was the account of one participant who 
described a period of doubt about her decision to opt for RRM. 
Data analysis was planned to finalise when theoretical saturation was reached.  
However, the rate of participant recruitment limited the number of interviews conducted and 
there remains the question whether theoretical saturation has been confidently reached.  For 
this reason, participant recruitment and data analysis is planned to continue beyond the write 
up of the findings presented in this thesis. 
 
Reflexivity 
Personal and epistemological reflexivity are emphasised as important features of 
qualitative research.  The researchers acknowledge the impossibility of remaining ‘outside 
of’ the research being conducted, holding an awareness of how their own values, experiences 
or beliefs have shaped the research, and of how the study and methods used might have 
defined and limited the data and the findings (Willig, 2008). 
In this respect, prior to the commencement of the study, the researcher did not have any 
personal or professional experience with breast cancer.  However, when the analysis was 
being completed, the researcher worked as a trainee clinical psychologist in a psycho-
oncology service and conducted RRM consultations with patients requesting this procedure.  
It is possible that the researcher’s stances of positive regard and of respectful curiosity 
towards people affected by cancer may have impacted upon the interactions with participants.  
Additionally, the interviewing researcher being a woman might have also influenced 
participants’ interactions during interviews.  Another example pertains to the limitations of 
the methods of data collection, which have been discussed previously. 
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Validity 
Standards by which the developing analysis was assessed included theoretical and 
catalytic validity, i.e., potential utility for practice and research (Kincheloe & McLaren, 
2000).  This was achieved by considering the possible implications of the findings for clinical 
practice and for further research.   
 
Trustworthiness 
Issues of quality in qualitative research have been approached with a focus on 
achieving trustworthiness through the conduct of this study, with particular attention paid to 
the following four criteria, as suggested by Guba (1981) and Shenton (2004):  
Dependability.  In order to make the research more dependable, the processes followed 
have been reported in detail.  This includes the research design and its implementation, how 
the data was gathered, and how it was analysed.  Records of data analysis meetings have been 
kept, as have documents which were refined throughout the study, providing an audit trail 
that is available for review.  Examples can be found in Appendices P and Q. 
Confirmability.  To ensure as far as possible that the study’s findings were derived 
from the data rather than correspond with the preferences of the researchers, care has been 
taken to explicitly recognise potential biases.  This study was preceded by another 
investigation which was part of the wider research project (Brown et al., 2017).  In light of 
the potential for the current study to pursue a biased convergence with these initial findings 
instead of expanding the conclusions, the researchers engaged in continuous efforts to falsify 
and corroborate the emerging analysis.  Additionally, the researchers have provided an in-
depth methodological description to allow the integrity of the research results to be 
scrutinised. 
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Credibility.  The following provisions have been made to increase the credibility of the 
study and of the findings: 
a.$ The procedures followed for this research, including the method of data analysis, 
were derived from those previously and successfully used in comparable studies. 
b.$ The researcher aimed to establish rapport with participants from the beginning.  
Participants were encouraged to be open and honest, for example by being assured 
that there were no right answers to the questions and that the researcher was interested 
in their particular experiences. 
c.$ Peer scrutiny of the study: the researcher presented and discussed the project to 
colleagues in academic settings, which encouraged the inclusion of a detailed 
explanation of the research design and of the method of data analysis. 
d.$ Background and experience of the investigators: the credibility of the researcher and 
of the wider research team is important.  All researchers had prior experience of 
conducting research in clinical settings. In particular, the trainee clinical psychologist 
was experienced in the conduct of semi-structured interviews and had extensive 
experience of working individually with people to gather information about sensitive 
topics in a respectful manner. 
e.$ Previous research findings and published literature have been examined, in order to 
relate the results of this study to the growing body of knowledge. 
Transferability.  The generalisability or transferability of the findings to other settings 
has been attempted through the description of relevant characteristics of study, including 
information about the data collection, about the participants, as well as about the wider 
context in which the findings are situated. 
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APPENDIX O 
EXAMPLE BRIEF NARRATIVE OF INTERVIEW 
For further details see data CD. 
 
Interview 1: 
This participant was a middle-aged woman, mother of three teenagers, in a relationship 
with a supportive husband, and was a carer for her sister.  She had previous history of breast 
cancer, and her diagnosis of breast cancer two years ago had been due to a series of fortuitous 
events, including a fall that required medical attention.  She has nursed and lost several 
family members to cancer in the past, including her mother, her brother and her aunt.  She 
reported not hesitating to have a contralateral RRM because she wanted to know that she had 
done all she can to get rid of the risk of cancer and to be there for her children for as long as 
she can, describing her children as her 'driving force'.  
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APPENDIX P 
EXAMPLE OF INITIAL ANALYSIS FOR AN EMERGING CATEGORY 
 
April 2017 
&
Category:&Safety&from&
worry&
&
Possible&Subthemes&
&
•$ Being!at!risk!of!breast!
cancer!leads!to!
heightened!worry.!
•$ Feeling!at!risk!leads!to!
wanting!to!do!something!to!
feel!safe.!
•$Other!risk!management!
alternatives!would!not!get!
rid!of!worry.!
•$ Consideration!about!other!
risk!managements!
alternatives!was!very!brief.!
•$ Consideration!about!other!
risk!managements!
alternatives!might!happen!
after!RRM!decision.!
•$ Eliminating!uncertainty!only!
achieved!with!RRM.!
!
Quotes:&Safety&from&worry&
ID06:!when!I!went!to!the!genetic!counselling!woman!and!she!said!there’s!chemo!like!
preventative!chemotherapy!and!high!risk!screening!that!very!quickly!for!me!I!
thought!well!then!you’re!living!that!same!shit!every!single!year!–!pardon!my!French!
–!you’re!going!to!go!through!that!every!year.!Are!they!going!to!find!anything!this!
year?!So!that!…!I!never!even!thought!about!it.!
RRR!
ID05:!Well!exactly!because!even!though!it!would!make!a!little!difference!R!it!might!
only!be!a!slight!difference!R!that’s!a!slight!difference!less!chance!of!me!getting!breast!
cancer!again.!
RRR!
ID05:!I’m!thinking!I!can!have!yearly!mammograms!and!have!that!thought!in!my!mind!
all!the!time!or!every!time!I!go!for!my!mammogram!I’m!going!to!be!worrying!are!they!
going!to!find!something!or!I!can!have!a!mastectomy!and!I’m!never!going!to!have!to!
worry!about!that!again!am!I?!
RRR!
ID05:!I!just!think!I!need!to!do!…!I!just!need!to!do!it!for!my!own!peace!of!mind!as!well!
as!everybody!else’s!as!well.!
RRR!
ID04:!I!can’t!have!things!hanging!over!me,!and!particularly!the!fact!that!it!could!
come!back.!I!couldn’t!live!with!that!…!and!not!do!anything!about!it.!
RRR!
ID04:!Because!if!you!get!over!the!first!one!and!you’ve!still!got!a!boob!and!the!
chances!are!that!maybe!5!years!down!the!line!it’s!going!to!pop!it’s!head!up!again,!
like!I!say,!you!don’t!know!at!what!stage!where!it!is!in!your!body!and!for!me!that!risk!
is!not!worth!taking!so!if!I!was!talking!to!you!I!would!say!to!you!get!well,!get!over!it!
and!consider!it!because!the!other!option!is!just!horrendous.!
RRR!
ID04:! There’s!women!presenting!over!70!with!breast! cancer!and! I! thought! I’m!not!
waiting!to!go!down!for!a!mammogram!again!and!have!a!recall.!I’ve!been!through!all!
that!most!of!my!life!and!I!thought!I!don’t!want!that!again!so!let’s!have!that!out!the!
way.!
RRR!
ID03:!so!I!was!about!57!when!I!got!the!results.!She![nurse]!felt!that!I!didn’t!need!it!but!
then!the!genetics!result!was!a!30–50%!chance!of!developing!cancer,!which!I!thought!
was!still!quite!high.!And!of!our! family! there!are!actually!only!4! ladies! in!our! family!
who’ve!got/developed!breast!cancer.!Two!were!young!and!two!were!my!age!so!I!don’t!
feel!I’m!out!of!the!risk!region.!
RRR!
ID02:!And!there!was!a!period!of!quite!a!lengthy!spell!from!when!I!found!the!lump!to!
getting!any!treatment!or!having!it!acknowledged,!and!I!thought!that!uncertainty!for!
me!was!more!worrying!than!the!op,!I!could’ve!dealt!with!the!op!quite!quickly,!get!it!
all!over!and!done!with!
RRR!
 
For further details see data CD. 
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APPENDIX Q 
EXAMPLE OF CONCEPTUAL CATEGORIES IN DATA ANALYSIS 
 
For further details see data CD. 
1.' “So&it&was&just&immediate&that&I&made&that&decision”&&
R$ Descriptive!finding,!explaining!context!of!how!the!decision!was!reached.!
R$ Homogeneity!in!the!decision!immediacy!and!the!degree!of!certainty!reported!by!
participants.!
R$ RRM!is!simple!conceptually,!e.g.!breast!tissue!removed!=!breast!cancer!cannot!occur.!
R$ DecisionRmaking!moments!were!difficult!to!access!in!detail,!i.e.!how,!not!why,!the!
decision!was!reached!in!that!particular!moment.!!
R$ This!might!explain!the!decision!being!immediate!or!intuitive.!
R$ Theoretically!it!could!be!that!the!timeline!would!divide!into!2!–!weighing!things!up!
before!the!decision,!and!justifying!it!after,!but!preRdecision!timeline!is!very!short!$!
Continue!to!try!to!expand!the!first!part!of!the!timeline!in!future!interviews.!
!
2.' Relief&and&safety&
R$ RRM!perceived!as!a!way!to!terminate!the!immediate!worry!they!are!living!with.!
R$ Worry!related!to!the!illness!returning.!Safety!related!to!not!having!this!worry!always!
accompanying!them.!
R$ Worry!related!to!not!having!done!‘all!they!can’!to!protect!themselves!and!their!loved!ones.!
R$ Women!did!not!express!worry!after!RRM!about!cancer!metastases.!
R$ Once!RRM!decision!is!agreed!with!surgeon,!this!results!in!relief/feelings!of!safety.!
R$ If!women!knew!that!they!could!have!RRM,!the!worry!decreased!and!it!was!
sufficiently!tolerable!so!as!to!postpone!the!operation!without!an!increase!of!worry!
or!sense!of!vulnerability.!
R$ Relief/Safety!related!to!the!elimination!of!uncertainty!(e.g.!about!risk!of!developing!
BC,!about!difficulties!in!diagnosing!it,!etc.).!!
R$ RRM!perceived!as!a!more!certain!option!than!other!alternatives.!
R$ Other!risk!management!strategies!would!not!get!rid!of!the!worry!to!the!same!
degree.!
